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CHARACTERIZING POROUS PROTEIN CRYSTAL MATERIALS FOR APPLICATIONS 
IN NANOMEDICINE AND BIONANOTECHNOLOGY 
 
 
Protein crystals are biologically derived, self-assembling, porous structures that have been used 
for decades in structure determination via X-ray diffraction. Recently, however, there has been 
increased interest in utilizing protein crystals for their unique material properties—most notably, 
their highly ordered porous structure, innate biocompatibility, and chemical plasticity. The diverse 
topologies of protein crystals and the relative ease with which their chemical properties can be 
altered via genetic mutation or chemical modification offers a wider and more dynamic design 
palette than existing chemically-synthesized nanoporous frameworks. These traits make protein 
crystals an attractive new material for applications in nanomedicine and nanobiotechnology.  
The intent of this project is to demonstrate the application potential of porous protein crystal 
materials for use in nanostructured devices. This work highlights our efforts to: experimentally 
and computationally investigate macromolecular transport and interaction energies within a large-
pore protein crystal environment using time-lapse confocal microscopy, bulkequilibrium 
adsorption, and hindered diffusion simulation; assess the cytocompatibility of various cross-
linking chemistries for the production of biostable protein crystal materials for use in biologically 
sensitive environments; and create multifunctional textiles by covalently attaching various cross-
linked protein crystals to cellulose fibers in woven cotton fabrics. By pursuing this research, we 
hope to better understand porous protein crystal materials and leverage that knowledge to design 
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!! 1.1 SUMMARY 
The porosity, order, biocompatibility, and chirality of protein crystals has motivated interest 
from diverse research domains including materials science, biotechnology, and medicine. Porous 
protein crystals have the unusual potential to organize guest molecules within highly ordered 
scaffolds enabling applications ranging from biotemplating and catalysis to biosensing and drug 
delivery. Significant research has therefore been directed toward characterizing protein crystal 
materials in hopes of optimizing crystallization, scaffold stability, and application efficacy. In this 
overview article, we describe recent progress in the field of protein crystal materials with special 
attention given to applications in nanomedicine and nanobiotechnology. 
!! 1.2 INTRODUCTION 
Proteins are important biological macromolecules responsible for many catalytic, signaling, 
and structural functions within cells and tissues. The diverse functions of proteins and their innate 
biocompatibility are attractive qualities for applications in nanomedicine and nanobiotechnology. 
As such, a wide variety of peptide- and protein-based nanomaterials have been reported, ranging 
from peptide nanofibrils, nanotubes, and nanospheres to smart biomaterials derived from collagen, 









volumetric density and precisely repetitive 3D geometric presentation of constituent proteins 
(Figure 1.1). From a materials perspective, it can also be quite useful to focus on the negative space 
defined by excluding the protein matrix portion of the crystal. The remaining solvent channel 
arrays typically consist of interconnected porous networks of varying geometric configuration with 
pores ranging in size from 0.3 nm to 10  nm3,4 and in rare cases have been shown to be even larger 
(Figure 1.1B & 1.1C).5,6 The solvent content of protein crystals is most commonly found to vary 
between 27-65%,3 commensurate to zeolites and metal organic frameworks, both of which have 
widely reported utility for medical, catalytic, and sorption applications.7–9 One goal for this chapter 
is to assess the application prospects for engineered protein crystals in these domains. 
Historically, protein crystals have been used both for protein purification and structure 
determination via X-ray diffraction (XRD). While the former application has been widely replaced 
by chromatography techniques, protein crystal growth continues to be the dominant method for 
determining 3D protein structure. As a result, the Protein Data Bank (PDB)10 currently contains 
over 120,000 X-ray structures encompassing myriad packing arrangements and solvent channel 
geometries/topologies. With few exceptions, each such crystal represents an unexplored material 
since the structural biologists who grew the crystals were, in most cases, only interested in the 
detailed structure of the constituent molecules. This chapter will focus on the exceptions to this 
rule, i.e. the number of research studies that have noted the material advantages of solid-state 
crystalline proteins or have otherwise sought to repurpose protein crystals for diverse material 
applications.  
We begin by first providing a minimal general background on protein crystallization methods 








Figure 1.1. Various protein structures (Top) and their corresponding crystal scaffolds (Bottom) illustrating the diversity of pore sizes 
and geometries within this class of material; boxes delineate unit cells; Scale bars: 20 nm (A) tetragonal Hen Egg White Lysozyme 
(HEWL) (PDB Code: 2HTX) (B) CJ-1 protein (PDB Code: 5W17). (C) Major Tropism Determinant P1 (Mtd-P1) complexed with 
Pertactin extracellular domain (Prn-E) (PDB Code: 2IOU). Images created using PyMOL v1.7.4.4, Schrödinger, LLC. 
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and historical contributions made to the field of protein crystal materials, giving special attention 
to applications in nanomedicine and nanobiotechnology. 
!! 1.3 PROTEIN CRYSTALS 
"! 1.3.1 Crystal Growth 
The science of growing protein crystals has a rich history, dating back to the mid-1800s when 
Hünefeld first formed hemoglobin crystals by slowly drying the blood of an earthworm between 
two glass slides.11 The process of slow drying caused hemoglobin proteins to move from an 
undersaturated stable-state to a supersaturated metastable-state and eventually inducing 
hemoglobin nucleation. As the crystals nucleate and grow, they fall out of solution thereby 
lowering the soluble protein concentration and moving the saturation point back into the 
metastable region where crystal growth occurs without further nucleation (Figure 1.2).12 Since 
Hünefeld’s experiments, crystallization techniques have improved dramatically with the advent of 
easy-to-use crystal screening kits and high-throughput micropipetting robotics; however, the 
scientific principles behind protein crystallization remain the same. In general, protein crystals 
form when individual growth units self-assemble into an ordered crystalline scaffold through the 
formation of non-covalent interactions. This process occurs under precise conditions of reduced 
protein solubility which can be achieved by a variety of methods, the most commonly used being 
dialysis, vapor diffusion, or batch crystallization. 
Dialysis: Precipitating agents can be slowly introduced to a protein solution via dialysis. A 
protein solution is placed in a vessel separated by a dialysis membrane from a larger reservoir 
containing a higher concentration of precipitating agent. The concentration of precipitating agent 
surrounding the protein gradually increases thereby reducing the protein solubility and eventually 





Figure 1.2. A protein crystallization phase diagram based on varied protein and precipitant 
concentrations. Three commonly used crystallization methods are highlighted showing the path 
each method takes to produce crystals. Note that all paths need to reach the same destination, 
namely the nucleation zone, after which they make their way through the metastable zone, where 
crystal growth takes place, and eventually arrive at the solubility curve. • represents possible 
starting conditions. (A) Dialysis. (B) Vapor diffusion. (C) Batch crystallization. Reproduced from 
Chayen.  Acta Crystallogr. D Biol. Crystallogr. 1998, 54 (1), 8–15 with permission of the 
International Union of Crystallography. 
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Vapor Diffusion: The method of vapor diffusion crystallization can be generally divided into 
two categories: sitting drop and hanging drop. Both categories accomplish protein supersaturation 
by the same general principle. An aqueous protein solution droplet containing insufficient 
precipitant for crystallization is setup apart from a larger reservoir containing a high concentration 
of precipitant in a sealed vessel. Over time, the droplet is equilibrated with the reservoir via vapor 
diffusion of water and other volatile components. Loss of water increases both the protein and 
precipitate concentrations in the droplet leading to supersaturation (Figure 1.2B). This method is 
often favored by structural biologists for growing large single crystals with high diffraction quality.  
Batch Crystallization: Batch crystallization is achieved by adding precipitating agents directly 
to a concentrated protein sample so as to shift the solubility curve directly into the nucleation zone. 
In other words, the protein and precipitant are mixed at their final concentrations to achieve 
nucleation (Figure 1.2C). Due to the relative ease with which batch crystallization can be scaled 
up, this method is preferred for industrial scale applications in which many protein crystals are 
required. 
"! 1.3.2 Stability and Bioconjugation 
One factor that has historically limited the material application of protein crystals is their 
relative mechanical and thermal instability compared to other nanoporous materials such as 
zeolites. Protein crystals are highly fragile due to several factors. First, the irregular shape of the 
constituent proteins generally leads to non-specific packing arrangements with high solvent 
content and relatively small interfacial contacts (~570 Å2 on average) when compared to known 
specific interactions (~1,600 Å2 on average).13,14 Second, these interfaces generally include 
adventitious and solvent-dependent interfacial contacts that are weak and non-covalent. Third, 
shifts in solvent conditions can destroy desirable properties of the crystals in several ways:                
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i) solvents that increase solubility can simply dissolve the crystal; ii) solvents that decrease the 
solubility can drive disordered aggregation on the crystal surfaces; iii) even solvents that are 
compatible with an essentially isomorphous crystalline form can shatter the crystal if the solvent 
is introduced in a way that induces stress associated with crystal structure gradients. 
In sum, protein crystals grown in their mother liquor possess inadequate stability for most 
conceivable applications. To solve this stability problem, many groups have turned to chemical 
cross-linking to introduce covalent linkages, thereby generating extended bond networks 
throughout the protein crystal matrix. This method has proven to be effective, enabling protein 
crystals to withstand solution conditions well outside their crystallization environments.15–18 
Cross-linking and Bioconjugation Chemistries: Protein crystals are comprised of individual 
proteins (or complexes thereof) which are in turn composed of polymerized amino acids. There 
are 20 common amino acids bearing a variety of unique chemical functionalities. The most useful 
amino acids for cross-linking and bioconjugation chemistries are those with ionizable side chains: 
aspartic acid, glutamic acid, lysine, arginine, cysteine, histidine, and tyrosine (Figure 1.3).19 This 
collection of amino acids includes primary amines, thiols, and carboxylates—common chemical 
group targets for post-crystallization bioconjugation. The bioconjugation field is quite broad, but 
well established, with many research articles, reviews, and books dedicated to diverse 
bioconjugation chemistries directed at improving biomaterial stability, compatibility, or 
functionality; the book by Hermanson, in particular, is highly recommended.19,20 Here, we will 
briefly introduce the aldehyde and carbodiimide reagents most commonly used in current protein 
crystal material applications. 
Aldehyde cross-linkers (Figure 1.4A) have been widely used throughout history to stabilize 












Figure 1.4. (A) Aldehydes of varying length. (B) Formaldehyde cross-linking leads to a stable 
final conjugation product. (C) Monomeric glutaraldehyde cross-linking results in unstable Schiff 
base formation unless a reducing agent (e.g. NaCNBH3) is added, which leads to reductive 
amination.  
! 10!
early embalming chemistries, leather tanning, and more recently chromatin immunoprecipitation 
and cell fixation techniques.21 In 1964, Quiocho and Richards were the first to use glutaraldehyde 
(GA) to improve carboxypeptidase-A crystal stability in diffraction experiments.22 Soon after, they 
demonstrated the enzymatic activity of glutaraldehyde cross-linked carboxypeptidase-A crystals 
in aqueous solutions different from that of the mother liquor.23 Since then, aldehydes (Figure 
1.4A), specifically glutaraldehyde, have been the dominant cross-linking agents for the 
stabilization of protein crystals.24–26 Despite the ubiquity of glutaraldehyde cross-linking, the 
chemical basis is incompletely understood. In principle, formyl groups in aldehydes undergo 
nucleophilic attack by primary amines producing a Schiff base. In the case of formaldehyde 
(Figure 1.4B), this Schiff base can undergo a second nucleophilic attack by another primary amine 
to complete the cross-linking reaction.21 However, in the case of monomeric glutaraldehyde, two 
Schiff bases are formed via nucleophilic attack, but are not reduced (Figure 1.4C).19 Notably, 
Schiff base formation is reversible, leading to cross-link reversal, particularly in acidic conditions; 
reducing agents such as sodium cyanoborohydride (NaCNBH3) may be used to induce reductive 
amination leading to a stable final product. Intriguingly however, the actual glutaraldehyde cross-
linking end products appear to be stable even in acidic conditions without the addition of reducing 
agents.27 Thus, other chemical mechanisms, aside from Schiff base formation, are likely 
responsible for the exceptional stability of glutaraldehyde cross-linked materials. Migneault et al. 
outlined 13 known aqueous states of glutaraldehyde, which can range from monomeric to highly 
polymerized; these different forms of glutaraldehyde can interact with proteins by way of 8 
different reaction mechanisms.28 More recently, Yariv Wine and coworkers attempted to resolve 
the predominant reaction mechanism of glutaraldehyde cross-linking in hen egg white lysozyme 
(HEWL) crystals (Figure 1.1A) under acidic and alkaline conditions using X-ray diffraction and 
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mass- spectrometry analysis.29 They were able to resolve two distinct glutaraldehyde cross-links 
within HEWL crystals at different pH conditions. Both resolved cross-links were consistent with 
polymeric glutaraldehyde forms serving as the active species. 
 Carbodiimide agents catalyze the formation of amide bonds between amines and carboxyl 
groups (Figure 1.5).19 Unlike aldehydes, carbodiimides are “zero-length” cross-linkers, meaning 
they do not add additional atoms between the two conjugated molecules.  This process has been 
utilized to produce stable collagen matrices,30 and protein-based nanoparticles,31 crystals,32 and 
macrocomplexes,33 as well as conjugate enzymes to cellulose-based materials.34–36 1-Ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) is the most commonly used carbodiimide agent for 
protein conjugation, primarily due to its solubility in aqueous solutions. The other commonly 
available water-soluble carbodiimide is 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide (CMC). 
Most other carbodiimides, such as dicyclohexyl carbodiimide (DCC) and diisopropyl 
carbodiimide (DIC) are water-insoluble, making their use in protein conjugation more limited—
though they are widely used in organic synthesis of peptides.19 
 Biocompatibility of Protein Crystal Materials: Numerous alternative bioconjugation 
chemistries for the stabilization and functionalization of protein crystal materials are briefly 
outlined by Alexey Margolin and Manuel Navia.16 However, any chemical additive may have the 
unintended potential to negatively impact biocompatibility. In broad terms, a biocompatible 
material has low propensity to cause biological damage to the host upon contact. This damage may 
take the form of direct cell or tissue death (cytotoxicity), unintended immune responses 
(immunogenicity), or genetic mutations (genotoxicity).37 Decreased biocompatibility due to cross-
linking has been observed in various protein-based materials including collagen fibers38 and 






Figure 1.5. EDC reacts with carboxylic acids to create an active-ester intermediate. In the presence 
of an amine nucleophile, an amide bond is formed with release of an isourea by-product.   
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Biocompatibility testing of cross-linked protein crystal materials has only recently been 
pursued as protein crystal applications in nanomedicine become more widely apparent. For 
instance, Takafumi Ueno’s work on cross-linked hen egg white lysozyme crystals impregnated 
with ruthenium carbonyl complexes (Ru•Cl-HEWL) motivated their preliminary testing of 
cytocompatibility against human embryonic kidney cells.39 Using a solution of 0.5% trypan blue 
as an indicator of cell viability, they found no measurable cytotoxicity after 24 hours at the single 
concentration tested (2.0x105 crystals/well). More recently, our group has assessed the stability 
and biocompatibility of various cross-linking agents on two distinct protein crystal scaffolds: 
HEWL (Figure 1.1A) and CJ (Figure 1.1B).32 The cell viability of each cross-linked protein crystal 
material was assessed at varying concentrations (1, 50, 100, 200, and 400 µg/mL) against two 
human cell lines: adult human dermal fibroblasts (HDFa) and human macrophages (MV-4-11). 
Viability was quantified using a lactate dehydrogenase assay (Figure 1.6A, B, D) and qualitatively 
confirmed via live dead staining (Figure 1.6C). Results indicate that cell cultures subjected to high 
concentrations of glutaraldehyde cross-linked protein crystal materials (100 – 400 µg/mL) suffered 
noticeable loss in cell viability. However, no substantial loss in cell viability was observed in cell 
cultures subjected to protein crystal materials cross-linked by oxaldehyde (OA) or EDC. These 
results suggest that researchers should consider alternatives to glutaraldehyde when stabilizing 
protein crystal materials, particularly if the application requires biological amity. 
 Existing studies have only scratched the surface with respect to evaluating the biocompatibility 
of engineered protein crystals in the context of nanomedicine and nanobiotechnology. Future work 
that focuses on genotoxicity and immunogenicity is needed to understand the biological responses 
to these novel materials and to determine when alternative chemistries for the production of stable 
protein crystal materials will be needed.   
! ("!
 
Figure 1.6. (A) HDFa cell viability under varying concentrations of cross-linked CJ crystal 
materials; Error Bars: standard deviation, n=3. (B) HDFa cell viability under varying 
concentrations of fragmented HEWL protein crystal materials; Error Bars: standard deviation, 
n=3. (C) HDFa cells incubated with 400 !g/mL protein crystal material; Top: green fluorescent 
live cell stain (calcein); Bottom: red fluorescent dead cell stain (ethidium homodimer); Left: 
CJ/GA, Scale Bar: 100 !m; Right: CJ/EDC, Scale Bar: 300 !m. (D) MV-4-11 cell viability when 
incubated with various protein crystal materials at a concentration of 400 !g/mL; Error Bars: 
standard deviation, n=3. Adapted from Hartje et al. ACS Biomater. Sci. Eng., 2018, 4 (3), 826–831 
and reprinted with permission from The American Chemical Society.  
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!! 1.3.3 Porosity and Guest Transport 
Myriad applications for engineered protein crystals depend on transport rates and/or molecular 
interactions between guest molecules and the pore surfaces of scaffold materials. For instance, 
enzyme crystal biocatalysis applications are sensitive to the ratio of crystalline pore size to the size 
of the substrates and products, as mass-transfer rates can limit the net activity for cross-linked 
enzyme crystals of sufficient size.40,41,23 Similarly, in the case of chromatography, the separation 
capability of protein crystals is dependent on three modes of physical segregation: adsorption, 
diffusion, and size exclusion—all of which are influenced by mass transport. Therefore, 
understanding transport within protein crystals is an important first step in advancing their material 
applications. To this end, many groups have sought to quantify the transport of solvent, small 
molecules, and macromolecules within the pore networks of various protein crystals. In this 
section, we will review some of the more common experimental and computational techniques 
utilized to study pore networks and guest transport within protein crystals. 
Experimental Approaches: One of the earliest studies of diffusion within protein crystals was 
reported in 1941 by Sam Granick who showed guinea pig hemoglobin crystals to be permeable to 
ferricyanide and hydrosulfite by monitoring oxidative colorimetric changes caused by the 
hemoglobin oxygen.42 Granick’s work helped to confirm the porous nature of protein crystals well 
before the first protein crystal structure was solved in 1958 by John C. Kendrew and coworkers 
using X-ray diffraction (XRD).43 Over two decades later, in 1968, quantitative diffusion studies of 
bromine-containing solutes within cross-linked !-lactoglobulin crystals was performed by 
William H. Bishop and Fredric M. Richards using X-ray fluorescence measurements.44 By 
understanding the material properties of protein crystals, Bishop and Richards generated 
quantitative transport data as a function of time and estimated the effective pore size of the solvated 
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channels. Their work not only advanced our understanding of hydration shells surrounding 
biomolecules, it also emphasized the usefulness of protein crystals as model systems to study 
transport phenomena. Since then, other quantitative methods, such as video absorbance 
spectroscopy45 and fluorescence microscopy46 have been implemented to study time resolved 
transport of guest molecules into protein crystals. 
One major limitation of these early transport experiments was the inability to accurately 
resolve the precise position of guest molecules within the path length of the crystal. More recent 
confocal microscopy methods overcome these limitations and observe transport in protein crystals 
as a function of both time and position. Confocal microscopes can illuminate specific focal planes 
within protein crystals and thereby resolve the relative concentration of fluorophores within spatial 
slices. In the early 2000’s, Aleksandar Cvetkovic and coworkers were the first to use 3D confocal 
microscopy to study small molecule transport within protein crystals.47,48 Their early work 
monitored the 3D diffusion of fluorescein within tetragonal, orthorhombic, and triclinic HEWL 
crystals. Later, they applied this technique to quantify the binary diffusion of fluorescein and 
rhodamine B within HEWL crystals (Figure 1.7A).49 Using confocal microscopy data, they fit their 
observations to anisotropic diffusion models and found that transport diffusivities were strongly 
related to pore size (Figure 1.7B). By linking mathematical models for guest molecule transport to 
experimental confocal data, Cvetkovic and associates provided valuable insights and tools to 
understand complex systems where the functional properties depend on the intra-crystal transport 
of one or more guest molecules. 
Mathematical transport models are limited by the requirement to reduce model complexity. In 
the case of guest molecule transport inside porous host materials, this is often done by assuming 






Figure 1.7. (A) Co-diffusion of fluorescein (left) and rhodamine B (right) in a cross-linked HEWL crystal. (B) The pore diffusion 
coefficient (Dp) is related to the ratio of guest substrate diameter (ds) to pore diameter (dp). A & B adapted from Cvetkovic et al. J. Phys. 
Chem. B, 2005, 109 (21), 10561–10566 and reprinted with permission from The American Chemical Society. (C) The adsorbed guest 
concentration (q) causes occlusion of the scaffold pore leading to attenuation of Dp. Reprinted from Hartje et al. J. Phys. Chem. B, 2017, 
121 (32), 7652–7659 with permission from The American Chemical Society.
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assumptions represent significant over-simplifications for most actual crystal scaffold host-guest 
systems. Furthermore, adsorption of guest molecules can occlude small pores. As one would 
intuitively expect, strong adsorption can greatly attenuate the diffusion coefficient when pore 
occlusion reduces the effective pore diameter so as to only permit single-file guest diffusion 
(Figure 1.7C).50–52 Thus, accurate modeling of diffusion must account for adsorption, thereby 
further complicating any mathematical model of diffusion within the context of porous protein 
crystals. To alleviate some of the complexities and assumptions associated with mathematical 
diffusion modelling within protein crystal systems, a number of research groups have instead 
turned to numerical simulations that embrace the complex details of the guest molecule and pore 
structures. 
 Computational Approaches: Molecular simulation of guest transport within protein crystal 
pores can more accurately account for the complex environment of protein crystal solvent 
channels. The increased realism comes with a price; atomistic simulations are much more 
computationally costly than the simplified mathematical models. Atomistic simulations have 
therefore been severely limited in their ability to generate enough trajectory data for accurate 
representations of the statistical ensembles describing transport phenomena. However, with 
modern advancements in computer science, atomistic simulation of small molecule guest transport 
has become more attenable. Brownian dynamics,53,54 Monte Carlo,55,56 and molecular 
dynamics54,57–61 approaches have all been used to investigate small molecule transport within 
protein crystals.  Kourosh Malek has put together a comprehensive two-part review that details the 
various simulation techniques used to model diffusion within protein crystal materials.62,63 We will 
therefore not cover these techniques in detail here. Notably, these methods have not yet been 
extended to study macromolecular guest transport over long timescales.  
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Given the expense of molecular simulation, it can be useful to also perform a static analysis of 
the crystal structure. In particular, understanding the solvent channel environment of protein 
crystals is critically important for diverse protein crystal applications including catalysis, 
chromatography, biotemplating, and drug delivery. Multiple software packages have been created 
to aid in the identification of pores, channels, and cavities and better model their physiochemical 
environments. In 1994, Oleg Kisljuk and coworkers developed CHANNEL, a software package 
designed to identify channels within protein crystals by building up a spatial graph of intersecting 
spheres of defined radii to elucidate interconnected cavities within the unit cell.64 More recently, 
Douglas Juers and Jon Ruffin have developed MAP_CHANNELS, a computational tool designed 
to aid in the visualization of solvent channels in macromolecular crystals and to quantitatively 
characterize those channels with metrics relevant for the study of guest molecule transport.65  
!! 1.3.4 Engineering Protein Crystals 
The chemical versatility of proteins, combined with the intrinsic porosity of protein crystal 
scaffolds suggests that protein crystals can be engineered to become useful biologically derived 
nanomaterials. In this section, we will discuss the many efforts to engineer protein crystal scaffolds 
to optimize stability, biocompatibility, transport dynamics, and surface functionality. Modification 
of the scaffold constituent proteins by site directed mutagenesis can be a particularly powerful 
engineering tool to direct desired chemical functional groups to specific locations within the 
scaffold. For example, crystal interfaces can conceivably be engineered to incorporate cysteine or 
histidine residues to promote disulfide bond formation or metal coordination, respectively, at 
protein contacts within the crystal. Below, we will review engineering studies that utilized these 
functional groups to generate protein crystal scaffolds with intriguing characteristics for 
applications in nanomedicine and nanobiotechnology. 
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Engineering Scaffold Interfaces: Novel protein crystal scaffolds can be generated by 
synthetic symmetrization of the crystal component proteins. Symmetrization of component 
proteins can be achieved by adding disulfide linkages or metal binding sites to direct 
oligomerization prior to crystallization. For example, in 2006, Rey Bonatao and coworkers in Todd 
Yeates’ lab generated three single-cysteine mutant variants of T4 lysozyme (T4L) prepared as 
symmetric dimers through a disulfide linkage.66 These three mutant dimers were shown to form 
six novel protein crystal scaffolds. In similar fashion, the Yeates group went on to create symmetric 
structures through metal coordination with engineered histidine or cysteine residues on both T4L 
and maltose binding protein (MBP).67 Oligomeric states were generated upon addition of metal 
ions: copper (Cu2+), nickel (Ni2+), or zinc (Zn2+). These symmetric oligomers were shown to form 
sixteen unique crystal lattices. This method, metal-mediated synthetic symmetrization, has the 
potential to expand the known crystal structure repertoire and could help crystallize proteins that 
have proven difficult to grow using conventional methods. 
Engineered disulfide bonds and metal coordination can also be used to increase crystal stability 
without relying on the addition of chemical cross-linking agents, thereby potentially increasing 
overall crystal biocompatibility. An early successful introduction of disulfide cross-links at 
protein-protein interfaces was reported in 2000 by Yang et al.68 In this case, the crystallographic 
interfaces within T4L was used to model cysteine mutants that would create disulfide cross-links. 
Polymers of T4L were then made both from lysozyme in solution and crystallized lysozyme 
mutants by exposing the protein to oxygen. The yield of polymers was much higher from oxidized 
crystals than oxidized monomers in solution. Interestingly, these polymers were exploited as a 
means of studying monomer unfolding by mechanical stress through scanning force microscopy 
(SFM)  
! 21!
A couple years later, in 2002, Srinivasan et al. promoted disulfide cross-linked protein crystals 
as a way to form protein fibers which they called crystine.69 The disulfide modeling program 
MODIP was used to predict sites in 15 crystallographic interfaces that would support disulfide 
cross-linking. Only one out of three designs produced was successfully crystallized. The authors 
noted that even though the cross-linking was only one-dimensional, the crystals were difficult to 
dissolve. Dissolution of these crystals resulted in bundled fibers with diameters up to 7 nm in 
which several cross-linked chains were held together by non-covalent interactions. In contrast to 
the random three-dimensional network produced by glutaraldehyde cross-linking, disulfide cross-
links preserved the order of a protein crystal at specific sites along crystal interfaces. In 2014, 
Esben Quistgaard demonstrated the use of disulfide cross-linking within crystals composed of 
vDED coiled-coil domain dimers from human BAP29.70 These crystals form honeycomb-like 
scaffolds with complete disulfide cross-links along the c-axis (PDB Code: 3W7Y, Figure 1.8A). 
Per MAP_CHANNELS, the major axial pores are large enough to accommodate 1D diffusion of 
7 nm diameter guest spheres, though the short unit cell height (3.1 nm) would preclude some 
applications. Finally, Heinz and Mathews reported that designed intermolecular disulfide cross-
links in T4L resulted in more rapid crystallization.71 
 Similarly, protein crystal scaffold interfaces can be engineered to display surface histidine (or 
histidine motifs) that can coordinate metal ions and stabilize the crystal lattice. In 2010, Robert 
Radford and others working in Akif Tezcan’s group implemented a bottom-up strategy to direct 
protein self-assembly using supramolecular metal coordination chemistry in the production of a 
porous protein crystal framework.72 Their engineered protein (MBPPhen2) was derived from a 
four-helix bundle heme protein (cytochrome cb562) and was shown to readily crystallize in the 
presence of Ni2+ or Zn2+ ions  (Figure 1.8B).  The resulting scaffold  (PDB Code: 3NMK)  contains  
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Figure 1.8. (A) disulfide linkages within a porous protein crystal scaffold. Adapted from 
Quistgaard. Chem Commun 2014, 50 (95), 14995–14997 with permission from The Royal Society 
of Chemistry. (B) Schematic of zinc mediated crystal formation of MBPPhen2 illustrating resultant 
lattice porosity. Reproduced from Radford et al. Chem. Commun. 2010, 47 (1), 313–315 with 
permission from The Royal Society of Chemistry. (C) Schematic of metal mediated coiled-coil 
crystal assembly. Reproduced from Nepal. J. Am. Chem. Soc. 2016, 138 (34), 11051–11057 with 
permission from The American Chemical Society.  
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hexagonal pores, the largest of which could accommodate a spherical guest with 4.6 nm diameter 
(per MAP_CHANNELS). More recently, metal-coordination has been used to direct coiled-coil 
self-assembly in the production of crystal scaffolds. Both Jean Chmielewski’s group (Figure 
1.8C)73 and Seth Horne’s group74 have used peptide engineering and metal-coordination to 
produce self-assembling crystalline scaffolds with tunable morphologies. 
Other methods of engineering scaffold interfaces include hydrophobic patch design, ligand-
mediated crystallization, and natural dimer and trimer fusion proteins. All of these approaches 
have led to unique artificial protein crystals. These methods and others are reviewed in detail by 
Satoshi Abe and Takafumi Ueno.75 
Engineering Crystal Surfaces and Pore Environments: Site-specific modifications of protein 
constituents can improve or expand protein crystal functionality, producing novel scaffolds with 
uniquely desirable traits. For instance, surface modification of protein crystals with secondary 
molecules capable of binding cell surface markers could prove beneficial in directing crystals to 
specific tissue types in drug delivery applications.  Takafumi Ueno’s group has shown the ability 
to decorate the surface of polyhedral crystals (PhC) with Lewis X (LeX) carbohydrate by 
modifying surface cysteine residues using established maleimide and click chemistry (Figure 
1.9A).76 Alternatively, the Chmielewski metal-coordination driven coiled-coil assembly that was 
described above (Figure 1.8C) was also shown to direct guest molecules to distinct crystal surfaces 
(Figure 1.9B).73  
Other crystal engineering efforts have focused on modification of the interior surfaces. Pore 
structure and the physicochemical character of the interior crystal surfaces are critically important 
for the  overall performance properties  of protein  crystal materials  that include  guest molecules.   
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Figure 1.9. (A) Schematic representation of LeX immobilization on the surface of PhC: (i) 
cysteine residues of PhC modified with propargyl maleimide; (ii) acetylene moieties modified with 
LeX-azide via copper-catalyzed azide-alkyne cycloaddition; (iii) antibody-antigen reaction on the 
surface of modified PhCs.  Reproduced from Abe et al. Chem. Lett. 2014, 44 (1), 29–31 with 
permission from The Chemical Society of Japan (B) Schematic representations for directing His-
tagged fluorophore guests to protein crystals: (i) on the surface after crystal formation, (iii) within 
the crystal during formation, or (v) at both the surface and within crystals. (ii, iv, vi) Bright-field 
(left) and confocal (right) microscopy images. Reproduced from Nepal et al. J. Am. Chem. Soc. 
2016, 138 (34), 11051–11057 with permission from The American Chemical Society. (C) 
Confocal imaging of an interior plane within a highly porous CJ crystal, demonstrating spatially 
segregated macromolecular guests (mNeonGreen and mCherry) immobilized with Zn2+. 
Reproduced from Huber et al. Small 2017, 13 (7), 1602703 with permission from The Royal 
Society of Chemistry.  
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Accordingly, there have been multiple attempts to modify protein scaffolds to optimize specific 
properties related to transport, catalysis, and templating. In 2009 & 2011, Felix Frolow and 
Amihay Freeman’s group used both systematic mutation of pore surface residues to alter the 
porosity of HEWL crystals in the interest of biotemplating applications.77 They furthermore 
investigated the possibility of utilizing metal-mediated crystal-packing to affect the pore size of 
HEWL crystals via simple addition of various metal ions (Co2+, Ni2+, Cu2+, Zn2+, Cd2+) to the 
crystal growth environment. However, this approach resulted in limited changes to crystal packing 
and overall porosity.78 
 Our group has recently engineered metal coordination sites on the interior pore surfaces of CJ 
protein crystals (Figure 1.1B), to exert spatial and temporal control over macromolecular guest 
installation within the crystal scaffold (Figure 1.9C).79,80 We used stepwise guest loading and 
EDTA as a metal chelator to demonstrate secure immobilization and precise segregation. These 
results illustrate the capacity of protein crystal materials to organize trillions of guest molecules in 
3D with robust control over localization and release. Efforts to modify surface and pore 
functionality of protein crystal scaffolds have enhanced the prospects for using engineered protein 
crystals as host matrices for drug storage, delivery, and release with exciting implications for the 
future of nanomedicine. 
!! 1.4 APPLICATIONS IN NANOMEDICINE 
"! 1.4.1 Pharmaceutical Formulations 
The simplest route through which protein crystals can benefit nanomedicine is the use of non-
cross-linked protein crystal formulations for drug delivery. Alexey Margolin and Manuel Navia 
have outlined several significant advantages crystallization can offer from a therapeutic 
perspective: i) crystallization can streamline the manufacturing process by providing a means of 
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protein purification; ii) crystals are the most concentrated form of proteins, which is beneficial for 
high-dose delivery; iii) crystal dissolution is dependent on crystal morphology, which enables 
optimization of a slow dose release regimen by altering the crystal size and shape; iv) lastly, dry 
crystal formulations are known to have improved physical and thermal stability over their soluble 
or amorphous couterparts.81 In 2003, Alexey Margolin’s group went on to demonstrate the 
feasibility of crystallizing monoclonal antibodies (mAbs) in large quantities using batch 
crystallization methods.82 Their work generated functional crystalline suspensions of three 
approved therapeutic mAbs with yields of 85-95%. Crystal morphologies could be tuned by 
manipulation of the batch crystallization protocol to generate optimal formulations for 
subcutaneous delivery in high concentrations. They have subsequently written an expert opinion 
piece focusing on the use of protein crystals for the delivery of biopharmaceuticals, which 
describes the benefits, challenges, and techniques associated with this technology.81 In addition to 
this work, experimental83–86 and computational87–94 studies have characterized batch crystallization 
techniques for the generation of monodisperse sub-micron protein crystals of specific 
morphologies in the interest of industrial scale pharmaceutical formulations and drug delivery. We 
also note that microcrystalline suspensions offer potential advantages in terms of shelf-stability95 
and decreased viscosity which could enable delivery via smaller needles.81   
"! 1.4.2 Vaccine Delivery 
Subunit vaccines are ideally composed of highly purified and well characterized antigenic 
molecules that can be manufactured through chemical synthesis or recombinant DNA expression 
systems.96 Furthermore, subunit vaccine formulations provide superior safety over live-attenuated 
vaccines and thus may be administered to patients with weakened immune systems.97 The high 
purity and regularity of protein crystals, along with their biodegradability may provide significant 
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advantages over soluble subunit vaccine formulations by improving the immune response and 
limiting the need for additional adjuvants. For instance, in 1997 Wade-Evans et al. demonstrated 
70% reduction in mortality in mice immunized with a crystalline vaccine composed of the major 
outer core protein of African horse sickness virus, VP7.98  Protection was slightly improved (90%) 
when the VP7 protein crystal vaccine was administered along with Freund’s complete adjuvant. 
Both outcomes demonstrated significant improvement over the dramatic 80-100% mortality in 
non-immunized mice. In 1999, Nancy St. Clair working with Alexey Margolin and coworkers used 
cross-linked protein crystals composed of human serum albumin (HSA) to elicit an immune 
response in rats.99 They compared the HSA crystal vaccination response to that of soluble HSA 
and observed that cross-linked crystals were significantly more immunogenic as assessed using 
antibody titer counts. While this early work demonstrated the utility of protein crystals for use in 
vaccine delivery, recent progress on improving subunit vaccine immune responses has been 
primarily pursued by groups focusing on other forms of supramacromolecular structures, such as 
protein nanoparticles, cages, and viral-like particles.100–103 
"! 1.4.3 Drug Delivery 
Drug delivery is a broad field with tremendous impact on the future of nanomedicine. Aside 
from the previously mentioned pharmaceutical formulations, there are numerous drug delivery 
vehicles ranging from various nanoparticles101,104 to protein cages and artificial virus-like 
particles.105,106 One drug delivery avenue where protein crystal materials have been of recent use 
is in the delivery of gas signaling molecules. Carbon monoxide (CO) is a cell signaling molecule 
that mediates anti-inflammatory and vasoactive responses.107 Hiroyasu Tabe and associates 
working in Takafumi Ueno’s group used cross-linked HEWL crystals as a scaffold to immobilize 
ruthenium carbonyls, creating ruthenium carbonyl-incorporated cross-linked hen egg white 
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lysozyme crystals (Ru•CL-HEWL) with CO-releasing properties.39 They demonstrated the 
efficacy of Ru•CL-HEWL for the extracellular delivery of CO by treating cells with Ru•CL-
HEWL crystals and assaying the cellular response to CO (Figure 1.10A). Specifically, they 
implemented a luciferase reporter assay to monitor nuclear factor kappa B activity. Similar cellular 
responses were generated using non-cross-linked polyhedral crystals (PhCs) spontaneously grown 
within, and purified from, insect cells.108 Ueno’s group went on to demonstrate photoactivatable 
release of CO from manganese carbonyl groups immobilized on non-cross-linked PhCs (Figure 
1.10B).109 This body of work illustrates the potential for porous protein crystal materials to be used 
as extracellular matrices for the metered delivery of signaling gases. Future work in this area may 
focus on alternate protein crystal scaffolds engineered to release a variety of biologically relevant 
gas molecules, such as NO, which has many therapeutic uses including antimicrobial and 
anticancer properties.110,111 
Multifunctional fibrous matrices offer another path for the delivery of therapeutics. 
Electrospun non-wovens have demonstrated the capacity for controlled release of therapeutic 
molecules—offering an intriguing drug delivery method with applications in wound dressings, 
transdermal delivery, and post-surgical intervention. Certain electrospun materials, such as those 
derived from poly-є-caprolactone (PCL), can be both biocompatible and biodegradable and can 
deliver a wide range of drugs from small molecules like antibiotics to biomacromolecules like 
protein drugs and nucleic acids for gene delivery.112,113 However, one challenge in electrospinning 
protein therapeutics into non-woven matrices is the common requirement to use organic solvents 
in the electrospinning process, which can lead to protein denaturation or aggregation. Recall 




Figure 1.10. (A) Bioluminescence intensity in the luciferase reporter assay for evaluation of NF-!B activity of HEK293/!B-Fluc cells 
in the presence of 1.0 ng/mL TNF-" after incubation with PBS buffer (as control), Ru#CL-HEWL, Ru#HEWL, CORM-2, and CL-
HEWL for 24 h. Reproduced from Tabe et al. Inorg. Chem. 2015, 54 (1), 215–220 with permission from The American Chemical 
Society. (B) Luminescence intensity in the luciferase reporter assay for the evaluation of NF-!B activity of HEK293/!B-Fluc cells in 
the presence of 10 ng/mL TNF-" after incubation for 12 hours with Mn#HTPhC, Mn#WTPhC, MnCO5Br and HTPhC, with the light 
irradiation for 20 min (white), 10 min (dot), 5 min (slashed) and without the light irradiation (black). Reproduced from Tabe et al. Chem. 
Commun. 2016, 52 (24), 4545–4548 with permission from the Royal Society of Chemistry. (C) Distribution of FITC-labeled lysozyme 
crystals in a PCL non-woven prepared using ~2 µm lysozyme crystals, a 25% PCL solution, and a drug loading of 5%. Reproduced 
from Puhl et al. Mol. Pharm. 2014, 11 (7), 2372–2380 with permission from The American Chemical Society. 
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demonstrating superior stability in aqueous-organic solvents than their non-crystalline 
counterparts. Sebastian Puhl et al. utilized the superior stability of protein crystals in the 
electrospinning process.114 Specifically, they incorporated non-cross-linked HEWL crystals into 
non-woven matrices via PCL electrospinning (Figure 1.10C) as a proof of principle for improved 
protein incorporation and release from electrospun non-woven matrices. In this case, dissolution 
of HEWL crystals could provide a sustained release of the constituent enzymes. Future work in 
the development of multifunctional fabrics may alternatively focus on using bioconjugation 
chemistries to directly and covalently attach porous protein crystals to pre-existing textiles. 
!! 1.5 APPLICATIONS IN BIOTECHNOLOGY 
"! 1.5.1 Catalysis 
After Quiocho and Richards’ studies on glutaraldehyde cross-linked carboxypeptidase-A 
crystals in the 1960’s,22,23 subsequent studies of cross-linked enzyme crystals (CLECs) progressed 
rather slowly with only a handful of studies in the 1970s that investigated glutaraldehyde cross-
linked subtilisin crystals 115 as well as crystals of carboxypeptidase A116 and B.117 It wasn’t until 
the early 1990s that CLEC technologies became widely considered for industrial applications 
when Nancy St. Clair and Manuel Navia published their work on thermolysin CLECs.118 Their 
study looked at the catalytic activity and stability of thermolysin CLECs in a broad range of 
aqueous-organic solvents that would normally cause non-crystalline enzymes to denature and lose 
activity. The superior stability of crystalline enzymes (after chemical cross-linking) allowed 
CLECs to operate well outside normal biological conditions. In 1995, Alexey Margolin’s group 
demonstrated that cross-linked crystals of lipase derived from Candida rugose could be used for 
enantioselective hydrolysis of chiral racemic esters.119 Their work showed lipase CLECs to have 
superior enantioselectivity over crude lipase extracts. Many examples of CLECs have since been 
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reported in the literature,15,120–128 providing new opportunities for biocatalysis. Today, CLEC 
catalysis has a notable role in industrial scale synthesis.129–131  
"! 1.5.2 Biotemplating 
Biology is replete with complex and intricate systems that exhibit ordered structures on the 
nanoscale level. As nanotechnology advances, researchers are increasingly turning to biological 
systems to aid in the construction of synthetic devices. Biotemplating is the process by which 
biological scaffolds such as proteins, DNA, viruses, and bacteria can help control the size and 
shape of inorganic nanostructures during synthesis. Protein crystal scaffolds have been identified 
as intriguing biotemplating candidates on account of their highly-porous regular structure. In 2006, 
Cohen-Hadar et al. assessed the feasibility of using cross-linked protein crystals as a biotemplating 
scaffold.25  To do this, they used cross-linked lysozyme crystals to template the assembly of a 
synthetic hydrogel while monitoring the gel synthesis process and crystal stability via X-ray 
diffraction. In addition to templating hydrogels, protein crystals have been used as molds during 
the synthesis of both quantum dots132 and carbon dots133 with tunable fluorescence, or to grow and 
coordinate gold nanoclusters134–137,80 and luminescent lanthanide complexes.138 There have been 
many other accounts of stabilized protein crystals being utilized as effective biotemplating 
scaffolds and catalytic vessels for the assembly of organometallic complexes and biohybrid 
materials. These efforts have been thoroughly reviewed by Takafumi Ueno’s group.139–143 
"! 1.5.3 Biosensing 
Detecting biologically relevant molecules has become an important aspect of many scientific 
disciplines, including the biomedical and biotechnology industries as well as environmental 
protection. Biosensors, a term coined in 1977 by Karl Camman, describes analytical devices that 
monitor changes in biological analytes including metabolites, biomolecules, supramolecular 
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structures, and whole cells.144 Most such devices can be analyzed in terms of three components 
that each handle a specific task: i) analyte recognition, usually performed by a biological element 
such as cell receptors, proteins/enzymes, or DNA; ii) signal transduction elements, that transform 
the detection event into a measurable electrical or optical signal; iii) signal detection, which 
converts the electrical or optical signal into a readable result. The efficacy and performance of 
biosensors are often limited by the affinity and selectivity of the initial biomolecular recognition 
event. Thus, biomolecular recognition sensitivity limitations can bottleneck the biosensor 
performance. 
As discussed above, protein crystals are highly concentrated, regularly repeating structures that 
can be either engineered or cross-linked to become remarkably stable. Furthermore, CLECs 
possess high specific activity toward their reactants, even under very low reactant 
concentrations,118 thereby enabling CLECs to perform well as biorecognition elements within 
biosensing devices. In 1999, Manuel Navia and Nancy St. Clair filed a patent for the use of 
glutaraldehyde cross-linked protein crystals as biosensors, providing evidence for thermolysin, 
elastase, asparaginase, lysozyme, lipase, and urease CLEC stability and catalytic activity.145 A 
fully realized example of a CLEC biosensor was later presented in 2001 by Arkady Karyakin’s 
group, in which they evaluated a glucose biosensor based on Prussian Blue and CLECs derived 
from glucose oxidase.146 Their study compared the performance of a commercially available 
glucose oxidase biosensor to their glucose oxidase CLEC sensor in terms of sensitivity, linear 
range, and operational stability. They found that glucose oxidase CLECs had remarkable 
selectivity and improved sensing and stability over the commercially available biosensor, 
establishing the potential for future devices to incorporate protein crystals when diagnosing and 
treating diabetes. 
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Protein crystal based biosensors have also been implemented in detecting organic pollutants in 
the interest of environmental science and conservation. In 2004, Jegan Roy and coworkers 
developed a biosensor based on a laccase CLEC for the detection of phenols.147 This study found 
that laccase CLEC biosensors possessed high activity and sensitivity over a 3-month period 
towards a variety of phenols: catechin, catechol, pyrogallol, guaiacol, ferulic acid, and 2-amino 
phenol. Their sensor could be useful in the detection of antioxidant phenols in foods and phenolic 
pollutants in wastewater. In 2008, Thanaporn Laothanachareon and associates used 
organophosphate hydrolase (OPH) CLECs to create a biosensor for the detection of 
organophosphorus compounds.148 Their design utilized crude OPH CLECs as opposed to more 
costly purified OPH. Notably, the OPH CLECs demonstrated similar sensitivity to biosensors that 
used pure OPH. This work established that relaxed purity requirements could facilitate 
economically viable crystal production for biosensors. 
Microfluidic and nanowell devices, with their small scale and highly tunable transport 
properties, have been widely used for screening protein crystal growth conditions, study 
crystallization kinetics, and develop crystallization phase diagrams.149–153 Interestingly, nanowell 
devices have also been used to better understand protein nucleation and growth in the formation 
of sub-micrometer protein crystals for applications in pharmaceutical formulation and biosensing; 
Liying Wang and coworkers developed a method of crystallizing proteins in patterned nanowells 
(Figure 1.11A).154 Their work demonstrated control over the localization of submicron crystals. 
Advancements in microwell protein crystallization has allowed for novel applications in 
microfluidic biosensing. For instance, Conejero-Muriel et al. have shown the feasibility of using 
CLECs  for continuous  analyte detection;  their platform,  termed OCER (optofluidic CELC-based  
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Figure 1.11. (A) SEM images of lysozyme crystals grown in 10-µm wells. Reproduced from Wang 
et al. J. Am. Chem. Soc. 2008, 130 (7), 2142–2143 with permission from The American Chemical 
Society. (B) (a) Schematic of the OCER platform: (1) inlet ports, (2) extra inlet port for injecting 
analytic solutions; (3) passive zigzag micromixer; (4) serpentine channel for droplet storage and 
cross-section depicting the layout of the solution-storage array; (5) image of the structures located 
before and after the serpentine channel to prevent any mobile crystal/aggregate from being dragged 
by the injected solutions; (6) outlet port for the crystallization and cross-linking solution to avoid 
any contamination of the sensing region; (7) multiple path configuration for the photonic detection 
system, allowing a large concentration range to be explored while maintaining the absorbance 
linear range; (8) 2D microlenses with air mirrors along the interrogation channel; (9) outlet port 
for the product solutions. (C) Operation of the solution trapping system during the injection of a 
green dyed solution. The meniscus of the flowing solution is observed when emptying the 
microfluidic device, while the solution trapping system retains nanoliter-sized droplets in the 
microwell array. (D) Lipase crystals obtained in the OCER platform and (E) after being cross-
linked with glutaraldehyde. Reproduced from Conejero-Muriel et al. Anal. Chem. 2016, 88 (23), 
11919–11923 with permission from The American Chemical Society.   
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enzymatic reactor), has implications in cost-effective next-generation lab on a chip applications 
(Figure 1.11B).155 
"! 1.5.4 Chromatography 
Chromatography is a widely-used technique for purifying both small molecules and 
biomacromolecules. The earliest example of using protein crystal scaffolds as chromatography 
media was presented in 1998 by Lev Vilenchick working with Alexey Margolin and associates.4 
In this seminal paper, they use macromolecular porosimetry to study the fully hydrated pore 
structures of various cross-linked protein crystal scaffolds. This technique utilizes size exclusion 
chromatography (SEC) experiments to estimate the apparent pore size distribution of porous 
media. In their study, they investigated cross-linked protein crystal slurries of thermolysin, two 
forms of lipase (derived from Candida rugose and Pseudomonas cepacia), as well as bovine and 
human serum albumins (BSA and HSA) in packed chromatography columns. Their results 
demonstrate the ability of protein crystal materials to repeatedly separate molecules based on size, 
chemical structure, and chirality without significant loss in separation efficiency or structural 
integrity. Other groups have since demonstrated myriad separation applications for various protein 
crystal scaffolds.156–158 
One challenge in the field of chromatography is enantioselective separation of racemic 
mixtures. The Vilenchick et al. results highlight the inherently chiral nature of protein crystals as 
a distinct advantage over other porous materials. Proteins and enzymes are composed of purely L-
amino acids resulting in the potential for enantioselective guest interactions. One of the most 
extensible schemes for enantiomer separations involving protein crystal scaffolds relies on 
antibody crystals. Antibody proteins possess high affinity and specificity toward their antigens; 
thus, antibody crystals could conceivably also possess high affinity and specificity toward their 
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antigen leading to the ability to distinguish chiral racemates. This idea was confirmed by Antti 
Vuolanto and coworkers in 2003 and 2004 when they demonstrated chiral separations using 
crystalline chromatography media derived from antibody Fab fragments.159,160  
Later, in 2009, Zhongqiao Hu and Jianwen Jiang utilized molecular dynamics simulations to 
explain the ability of protein crystals to separate chiral molecules. They first modeled the transport 
of various amino acids (Arg, Phe, and Trp) inside glucose isomerase crystals, providing insight 
into the relative velocities of each amino acid during separation.60 Later, they simulated chiral 
separation of racemic phenylglycines within thermolysin crystals, predicting the ability of non-
antibody protein  crystals to separate chiral mixtures.61 
!! 1.6 CONCLUSIONS 
The exceptional properties of proteins can be harnessed in the form of crystal scaffolds to 
generate advanced nanostructured devices and materials. Recent advancements in protein crystal 
material research and engineering have opened the door to intriguing applications. The controlled 
growth of protein crystals with defined size and shape has facilitated the synthesis of next 
generation materials. As we have discussed, cross-linked protein crystals are remarkably stable 
against mechanical disruption, solvent changes, and pH extremes. CLEC catalysts have been 
remarkably active and specific, even at elevated temperature and in aqueous-organic solvents. 
These properties have allowed CLECs to be successfully used as catalysts for industrial synthesis, 
organometallic complexes and biohybrid materials, as well as detectors and transducers in 
biosensing technologies.  
Future studies of protein crystal material applications should assess the economics of this 
technology. In 2012, Harvey Blanch and coworkers evaluated the best-case scenario for highly 
optimized enzyme expression, estimating the baseline production cost to be $10.14/kg.161 In the 
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case of protein crystal materials, the cost of bulk purification and crystallization would have to be 
included, thereby increasing this floor. The economics may nonetheless be favorable for high-
value per gram applications such as biomolecular sensing, pharmaceutical formulations, and drug 
delivery. In the short-term, protein crystals may still be too precious for bulk material applications, 
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!! 2.1 SUMMARY 
Large-pore protein crystals (LPCs) are orderedbiologically derived nanoporous materials 
exhibiting porediameters greater than 8 nm. These substantial pores distinguish LPCs from 
typical nanoporous scaffolds, enablingengineered LPC materials to readily uptake, immobilize, 
andrelease macromolecular guests. In this study, macromoleculartransport within an LPC 
environment was experimentally andcomputationally investigated by studying adsorption-
coupleddiffusion of Au25(glutathione)18 nanoclusters within a cross-linked LPC scaffold via time-
lapse confocal microscopy, bulkequilibrium adsorption, and hindered diffusion 
simulation.Equilibrium adsorption data is congruent with a Langmuiradsorption model, 
exhibiting strong binding behavior betweennanoclusters and the scaffold. The standard Gibbs 
free energy of binding is equivalent to −37.2 kJ/mol, and the maximum binding capacity of 1.25 
× 103 mg/g corresponds to approximately 29 nanoclusters per LPC unit cell. The hindered diffusion 
model showed good agreement with experimental data, revealing a pore diffusion coefficient of 















 equal to 13 cm3/mol·s and 1.7 × 
10−7 s−1, respectively. At higher nanocluster concentrations, the simulated pore diffusion 
coefficient could be reduced by 3 orders of magnitude to 3.4 × 10−10 cm2/s due to the effects of 
pore occlusion. This study demonstrates a strategy to analyze adsorption-coupled diffusion data to 
better understand complex transport of fluorescent macromolecules into LPCs. This approach fits 
the observable fluorescence data to the key molecular details and will benefit downstream efforts 
to engineer LPC-based nanoporous materials.  
!! 2.2 INTRODUCTION 
Conventional nanoporous materials derived from mesoporous silica, zeolites and metal-
organic frameworks (MOFs) have long been used in applications involving molecular separations, 
adsorbents, catalysis, and molecular storage—all of which rely on mass transport through the 
material void space. Thus, characterizing transport within nanoporous materials has historically 
been a critical step in engineering and optimizing new constructs. Experimental and computational 
diffusion studies of small molecules, solvents, and gasses within conventional nanoporous 
materials have been looked at extensively in the literature.162–167 In contrast, highly porous protein 
crystals represent a less explored class of self-assembling nanoporous materials that is chemically 
and structurally divergent from these more characterized antecedents. As such, large-pore protein 
crystals (LPCs) pose an exciting new area for nanoporous material research.  
Composed of numerous chiral constituents, protein crystals are biologically derived and can 
be engineered to contain varying functional groups by means of genetic mutation or post-
translational modification. Furthermore, chemical crosslinking has been shown to stabilize and 
reinforce protein crystals thereby increasing their tolerance to harsh conditions.15–18 The chemical 
diversity, functional versatility, and imbued stability of crosslinked protein crystals make them 
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promising targets for use as nano-structured scaffolds with potential applications in drug 
delivery,81,168,169 catalysis,16,170–172 biosensing,146–148 enantiomer separations4,61,157–159,173 and 
biotemplating.25,174–176  
While diffusion of low molecular weight solutes within protein crystals has been the subject 
of a handful of studies,44–49,177–179 to date, we are unaware of any quantitative experimental or 
computational characterization of macromolecular guest transport within porous protein crystals. 
This is due in large part to the restrictive size of typical protein crystal pores, which have been 
reported to range from 0.3-10.0 nm in diameter.4,16,44 However, pore sizes greater than 8.0 nm are 
considered highly atypical, generally requiring a less-common high-symmetry space group. The 
protein crystal used in this study is composed of CJ monomers, a modified form of a putative 
periplasmic isoprenoid-binding protein from Campylobacter jejuni. CJ derived large-pore protein 
crystals (CJ-LPCs) adopt the P622 space group, with unit cell dimensions of $, % = 179.59 Å, and 
& = 50.58 Å (Protein Data Bank ID: 2fgs), they also exhibit axial pore diameters of 13 nm and < 3 
nm diameter lateral pores (Figure 2.1). The uncommonly large pore structure of the CJ-LPC 
scaffold permits passive diffusion of diverse macromolecular guests such as gold nanoclusters80 
as well as various enzymes and fluorescent proteins.79   
Transport within nanoporous materials is known to be sensitive to the relative size and shape 
of both the scaffold pore and guest molecules; such that the diffusion coefficient declines rapidly 
as the guest diameter increases180. The aim of this study is to understand the transport 
characteristics of macromolecular guests within LPC materials. For this purpose, the adsorption-
coupled diffusion of Au25(GSH)18 nanoclusters within a CJ-LPC scaffold is investigated via 
confocal microscopy and equilibrium adsorption measurements. Intriguingly, CJ-LPC axial pores 




 Figure 2.1. (A.) CJ-LPC 13 nm diameter z-axial pores; Dashes: cross-section depicted in C. (B.) 
Au25(GSH)18 nanocluster;181 CPK spheres and sticks represent gold atoms and glutathione (GSH), 
respectively; Dashes: 3.38 nm hydrodynamic diameter determined by dynamic light scattering 
(APPENDIX I). (C.) Cross-section of single z-axial pore; Panel: < 3 nm diameter lateral pores. 
(D.) Left: CJ-LPC model depicting parallel non-intersecting cylindrical pores and guest 
Au25(GSH)18 nanocluster (not to scale). Right: CJ-LPC showing hexagonal morphology; Scale 
bar: 20 µm.  
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nanoclusters are intrinsically fluorescent and essentially spherical (Figure 2.1B), thereby making 
this host-guest pair an attractive model system for mass transport studies and enabling the 
experimental data to be fit to a dynamic transport model that includes a porosity-dependent 
variable diffusion coefficient as well as dynamic adsorption-desorption. 
!! 2.3 THEORY 
"! 2.3.1 Determining Diffusion Coefficients 
Macromolecular transport within nanoporous materials is a complex process involving both 
diffusion and guest-scaffold interactions. These interactions tend to decrease transport by means 
of adsorption and hindrance. Thus, to appropriately model guest transport, the continuity equation 
must incorporate a pore diffusion coefficient, '
(
, representing the free-solution diffusion 
coefficient reduced by finite interstitial volume and hindrance effects and two species of guest 
concentration—diffusive (mobile), ), and adsorbed (immobile), *: 





= ∇ ∙ '
(
∇)                          (Eq. 2.1) 
However, the relationship between adsorption and diffusion can be difficult to experimentally 
determine. For instance, while fluorescence microscopy has been used to monitor the rate of 
fluorescent guest infusion into lysozyme crystals,46,49,182 this method alone does not provide a 
means of separating the diffusive and adsorbed concentrations seen in the fluorescence intensity 
profiles. If all intensity values were assumed to be in the diffusive phase ()) Equation 2.1 would 







)                          (Eq. 2.2) 
Here, the effective diffusion coefficient, '
3
, represents an averaged diffusivity that does not 
explicitly account for adsorption or hindrance effects and can therefore misrepresent the details of 
the transport process. 
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One way to obtain accurate values for '
(
, is to perform fluorescence microscopy experiments 





However, if Equation 2.2 is utilized under adsorbing conditions, the actual interstitial pore 
diffusivity can be underestimated. Essentially, adsorption coupled to rapid diffusion can be 
mistaken for slow diffusion. Here, we demonstrate an alternative method to decouple fluorescence 
signals into diffusive and adsorbed guest pools using equilibrium adsorption data and a hindered 
diffusion model that incorporates adsorption kinetics and a variable pore diffusion coefficient. 
"! 2.3.2 Adsorption Model  
We began this study by quantifying the adsorption equilibrium between Au25(GSH)18 and the 
host crystal. There are multiple models explaining various types of adsorption processes, the most 
commonly used is Langmuir adsorption183,184. The following Langmuir equation can be used to fit 
equilibrium adsorption data184: 











              (Eq. 2.3) 
where *
9":
 is the maximum concentration capable of being adsorbed onto a given amount of host 
material and )
B
 is the free-solution concentration at equilibrium. The Langmuir adsorption 
equilibrium constant, C
D
, is related to the adsorption, !
"
, and desorption, !
#









 can be used to calculate ∆F°, the change in standard Gibbs free energy 
of adsorption:185,186 




)                  (Eq. 2.4) 
where I is the ideal gas constant, J is temperature in Kelvin, and P
Q
 is the molecular weight of 
the adsorbed guest. Multiplication by the molarity of water (55.5 mol/L) results in a dimensionless 
quantity within the logarithmic function (APPENDIX I). 
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Additionally, we can use the kinetic rate constants to determine the change in the adsorbed 
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*                (Eq. 2.5) 




) from the fixed parameter C
D
, we used a 
hindered diffusion model to fit these parameters to experimental confocal loading data. 
"! 2.3.3 One-Dimensional Hindered Diffusion Model 
It is well known that guest molecule diffusion in nanoporous materials is reduced by a 
combination of guest-scaffold hydrodynamic interactions and steric confinement180. This 
hindrance is dependent on the proximity of the guest to the pore wall and increases with decreasing 
pore size. Furthermore, guest molecules adsorbed to the scaffold take up pore volume, thereby 
effectively decreasing the pore size. Therefore, the process of adsorption leads to increased 
hindrance and the attenuation of '
(
(*).  
Various models in the literature explain the relation between pore diffusivity and free-solution 
diffusivity as a function of R, where R is the ratio of molecular guest radius over effective pore 
radius (R = I I
(
).180,187–189 Dechadilok and Deen180 showed the following relationship to be 
within 2% of empirical observation for diffusion of spheres in cylindrical pores in which R < 0.95:  




(1 + 1.125R ln R O− O1.56034ROO + O0.528155R
4  
                            OOO+O1.91521R[ O− O2.81903R\ O+ O0.270788R^O       
                                           O+OO1.10115R_ OO− OO0.435933R`)      (Eq. 2.6) 
In the present work, the guest molecular radius (I) is computationally approximated from the 
known guest molecular structure using a hydrodynamic bead model (HYDROPRO),190 while the 
free-solution diffusion coefficient, '
B
, is calculated using the Stokes-Einstein relationship:  












 is Boltzmann’s constant, J is the temperature in Kelvin, i is the solution viscosity (0.01 
g/cmO∙Os), and I
j
 is the guest hydrodynamic radius obtained via dynamic light scattering 
(APPENDIX I). The effective pore radius is ascertained for each location along the pore over time 
from the quantity of locally adsorbed guest molecules: 













               (Eq. 2.8) 
where m
n
 is Avogadro’s number and the internal term estimates the volume consumed per 
adsorbed guest (APPENDIX I).  
If transport is assumed to only occur in the interstitial pore volume along the z-axis, Equation 
2.1 can be simplified to a single dimension. Combining Equations 2.1 and 2.5 produces the final 
continuity equation describing adsorption-coupled hindered diffusion for spherical guest transport 
within a one-dimensional cylindrical pore: 
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#
*            (Eq. 2.9) 
Here, the effect of reduced interstitial volume and hindrance factors is represented by a temporally 
and spatially varying pore diffusion coefficient, '
(
(*), calculated from Equation 2.6.  
To describe diffusion into an empty crystal, initial conditions are set such that when 6 = 0, 










− O))             (Eq. 2.10) 
where !
9
 is the external mass transfer rate of the guest, )
B
3
 is the effective free-solution guest 
concentration at the crystal surface interface, and ) is the diffusive intrapore guest concentration 
just inside the crystal at the surface interface. r is the total size of the crystal along the z-axis and 
transport occurs from the surfaces of the crystal (p = 0, r) toward the interior midplane (p = r 2). 
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!! 2.4 EXPERIMENTAL SECTION 
"! 2.4.1 Materials  
The following chemicals were purchased and used without further purification. From Sigma-
Aldrich: dimethylamine borane complex (DMAB). From Acros Organics: glyoxal solution (40% 
in H2O). From Alfa Aesar: hydroxylamine solution (50% in H2O). From Promega: analytical low 
melting point agarose. From VWR: HEPES. From Fisher Scientific: NaCl. From J.T. Baker: citric 
acid. Other reagents from Thermo Scientific and Sigma-Aldrich were used to make mTacsimateTM: 
1.83 M malonic acid, 0.25 M sodium citrate, 0.12 M succinic acid, 0.3 M D-L malic acid, 0.4 M 
acetic acid, 0.5 M sodium formate, and 0.16 M sodium tartrate—titrated to pH 7.5. mTacsimateTM 
is a modified blend of TacsimateTM from Hampton Research that removes ammonium from the 
solution, which contains primary amines that interfere with protein crystal crosslinking.  
"! 2.4.2 Protein Expression 
The target gene CJ was modified from the gene vector encoding protein CJ0 obtained from the 
Protein Structure Initiative: Biology-Materials Repository (Genebank ID: cj0420, Protein Data 
Bank ID: 2fgs). For ease of uniform expression and purification, the CJ0 gene was codon 
optimized and the periplasmic signaling peptide deleted thereby yielding CJ. The CJ gene was 
encoded in expression vector pSB3 with a C-terminal 6xHis tag and expressed in Escherichia coli 
BL21(DE3) pLysS cells using a glucose/lactose induction system191 at 17° C for 36 hours.  Cells 
were lysed by sonication and the CJ protein purified via nickel affinity capture on a HisTrap HPTM 
column (GE Healthcare). A single chromatography step provided sufficient purity for 
crystallization. Purified CJ protein was buffer exchanged into 0.15 M NaCl, 10 mM HEPES, and 
10% glycerol at pH 7.5, concentrated to 15 mg/mL, and stored at -30° C until used. 
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"! 2.4.3 Crystallization and Crosslinking 
CJ-LPCs were grown overnight by sitting drop vapor diffusion at 20° C in 85-90% 
mTacsimateTM and 10% glycerol at pH 7.5. Prior to crosslinking, crystals were washed by loop 
transferring them into a 90% mTacsimateTM, 10% glycerol mixture at pH 7.5 for 16-24 hours. 
Crystals were then transferred into a fresh mixture of 90% mTacsimateTM, 10% glycerol at pH 7.5, 
and crosslinked for 2-4 hours by the direct addition of 1% glyoxal and 25 mM DMAB. The 
crosslinking reaction was quenched by transferring CJ-LPCs into a solution of 0.3 M 
hydroxylamine, 25 mM DMAB, 0.15 M NaCl, and 0.1 M citric acid at pH 5.0 for 2-4 hours. After 
crosslinking and quenching, crystals appear clear with hexagonal morphology (Figure 2.1D).   
"! 2.4.4 Nanocluster Preparation 
Au25(GSH)18 was synthesized and purified according to a previously published procedure.80 
Glutathione (308.1 mg, 1x10-3 mol) was added to a solution of HAuCl4 (98.7 mg, 2.5x10-4 mol) in 
50 mL methanol and stirred to combine. Initially the mixture is a yellow cloudy suspension, but 
turns clear and colorless after approximately five minutes of magnetic stirring. The mixture is then 
cooled at 0° C while stirring for 30 minutes. To this, a solution of NaBH4 (94.3 mg, 2.5x10-3 mol) 
in 12.5 mL ice H2O was added rapidly while stirring. The reaction was allowed to mix for one 
hour at room temperature. The precipitate was then spun down at 4,000 rpm in 200 µL of methanol 
containing 5.0 M NH4OAc and the supernatant discarded. The precipitate was washed twice more 
in the same solution. Au25(GSH)18 was then purified using a 24% polyacrylamide gel. Au25(GSH)18 
nanoclusters were extracted from the polyacrylamide using H2O and subsequently precipitated in 
200 µL of methanol containing 5.0 M NH4OAc. Finally, Au25(GSH)18 was dried and stored at 4° 
C. The hydrodynamic radius, I
j
, of these Au25(GSH)18 nanoclusters was evaluated via dynamic 
light scattering in 20 mM HEPES pH 8.0 at 20° C (APPENDIX I). 
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"! 2.4.5 Equilibrium Adsorption Experiments 
To determine the binding affinity of Au25(GSH)18 to the CJ-LPC pore walls the adsorption 
isotherm was determined by constant volume bulk equilibrium adsorption. Four replicate 
adsorption equilibrium experiments were set up as follows: multiple large (100-400 µm diameter) 
crosslinked CJ-LPC crystals of known volume (and by extension known dry weight) were 
transferred into 5 µL of 20 mM HEPES pH 8.0 containing varying concentrations of Au25(GSH)18 
nanoclusters. Samples were sealed and lightly shaken for several days. The absorbance of 
Au25(GSH)18 nanoclusters in the free-solution was measured at 235 nm on a Take3TM micro-
volume plate using an EpochTM spectrophotometer (BioTek Instruments) before and after the 
incubation. The concentrations were obtained by comparison to an absorbance standard 
(APPENDIX I). The adsorbed concentration of Au25(GSH)18 nanoclusters on CJ-LPC at 
equilibrium was determined via mass conservation and normalized to the total mass of CJ-LPC 
present. 
"! 2.4.6 Confocal Imaging Experiments 
Quantifiable time-lapse diffusion data was obtained by monitoring Au25(GSH)18 nanocluster 
uptake within crosslinked CJ-LPCs via confocal microscopy. Individual crystals were loop 
transferred into a 20 µL total volume microwell containing 2.0 µL of 0.4% low melting point 
agarose to prevent crystal movement during imaging (APPENDIX I Figure I.6). After 
immobilization, the remaining volume (18 µL) was filled with 1.5 mg/mL Au25(GSH)18 suspended 
in 20 mM HEPES pH 8.0. A vacuum greased coverslip was placed over the well to prevent 
desiccation. Images were taken such that the z-axis fell within the image focal plane to monitor 
florescence intensity changes through the crystal over time. All diffusion experiments were 
performed in triplicate on an Olympus IX81 spinning-disk confocal microscope with Photometrics 
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Cascade II camera, a 20×/0.5 numerical aperture objective with a 1x magnification changer, and 
an Intelligent Imaging Innovations (3i) phasor holographic photoactivation system. Excitation was 
achieved with a 561 nm diode laser and 692 ± 12.5 nm single bandpass emission filter. Freshly 
crosslinked and quenched CJ-LPCs were imaged to ensure the crystals were intrinsically non-
fluorescent prior to Au25(GSH)18 infusion. All images were acquired with SlideBook 6.0 software 
(3i) and exported in tagged image file format (.tiff). Images were quantitatively processed using 
MATLAB version 9.1.0 software (Natick, MA). 
"! 2.4.7 Hindered Diffusion Finite Element Model 









, in the boundary conditions (Eq. 2.10) gradually increases during early infusion as 
Au25(GSH)18 diffuses through the 0.4% agarose gel toward the crystal, eventually reaching the 
constant )
B
 value of 1.43 x 10-7 mol/mL (1.5 mg/mL). This behavior was modeled using the error-
function compliment for one-dimensional diffusion in a semi-infinite bath (APPENDIX I). The 
spatial dimension within the crystal (distance along the crystal z-axis) was discretized into one-
dimensional elements resulting in a set of ordinary differential equations (ODEs) in time, which 
were solved by an implicit ODE solver (ode15s) in MATLAB version 9.1.0 (Natick, MA). See 
Table 2.1 for all other parameters used. 
!! 2.5 RESULTS AND DISCUSSION 
"! 2.5.1 Adsorption Isotherm 
To quantify the binding affinity of Au25(GSH)18 to CJ-LPC pore walls, an adsorption isotherm 
was generated from equilibrium adsorption experimental data. After fitting the experimental data 
to both Langmuir and Freundlich isotherm models via least squares, it was determined that the 
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Langmuir model (Eq. 2.3) demonstrated slightly superior fit (Figure. 2.2, APPENDIX I Figure 
I.12).  
The Langmuir fit resulted in an adsorption equilibrium constant (C
D
) of 7.51 L/g, revealing strong 
binding behavior between nanoclusters and the scaffold—from Equation 2.4: tF° = -37.2 kJ/mol. 
The maximum binding capacity (*
9":
) was found to be 1.25 ×103 mg/g or approximately 29 
nanoclusters per LPC unit cell. Remarkably, the apparent 29 nanoclusters per unit cell corresponds 





 were later used as fixed parameters (Table 2.1), when tuning the free parameter !
"
 to best 
fit the observable confocal fluorescence data (i.e. the temporally and spatially varying sum of * 
and )). Note that !
#











"! 2.5.2 Processing Confocal Images 
Images obtained by confocal microscopy were taken with the confocal image plane passing 
through the crystal along the z-axis of diffusion; schematic illustration found in Figure 2.3A. 
Digital images of a single crystal being infused with Au25(GSH)18 nanoclusters were recorded at 
intervals of 2 min for the duration of 1 hour, representative images shown in Figure 2.3B. To 
increase the fluorescence signal-to-noise ratio, intensity values from a 150 µm tall horizontal slice 
through the center of the crystal were taken at each time point and collapsed into one dimension 
by averaging the pixel values in each column, thereby creating a mean fluorescence ray-trace along 
the axis of diffusion (Figure 2.3C). The crystal boundaries (p = 0, r) were determined using canny 
edge detection in MATLAB version 9.1.0 (Natick, MA). Intra-crystal fluorescence intensity 
profiles at representative time points are shown in Figure 2.4C.  
Lateral diffusion across the xy-plane was not observed in the confocal data, which is consistent 





Figure 2.2. Adsorption experimental data fit to a Langmuir isotherm model (Eq. 2.3). The 




Table 2.1. FEM Fixed Parameters  
Parameter Value                               
)
B
 1.43 x 10-7 mol/mL 
'
B
 1.27 x 10-6 cm2/s 
!
9
 4.81 x 10-3 cm/s 
*C
D
 7.85 x 107  cm3/mol 
**
9":
 7.16 x 10-5 mol/mL 




 6.50 x 10-7 cm 
J 293 K 
* Converted to appropriate units from equilibrium adsorption isotherm parameters assuming ideal 







Figure 2.3. (A) Schematic depicting orientation of the confocal image plane with respect to the 
crystal axes (not to scale). (B.) Representative images of fluorescent Au25(GSH)18 nanoclusters 
diffusing along the z-axis into an initially non-fluorescent CJ-LPC scaffold over the course of 1 
hour; Scale bar: 40 µm; Dashed box: 150 µm tall data slice. (C.) Schematic depicting the averaging 
of the columns in the data slice to obtain the processed fluorescence intensity distribution (not to 
scale), this process is repeated for every time point to generate a complete intensity profile.  
! 53!
Prior to calculating the pore diffusion coefficient, the fluorescence intensity values in Figure 2.4C 
were converted to units of concentration via fluorescence standard (Figure 2.4A-B). In addition, 
as the infusion from the two halves of the crystal should be symmetric given ideal external 
Au25(GSH)18 transport, the right and left sides of the concentration profiles were averaged together 
resulting in a final symmetric distribution (Figure 2.4D). Not only does the Au25(GSH)18 
concentration increase with time, but the distribution profile also changes, exhibiting a minimum 
in the center of the crystal that increases over time. Modest deviations in intrapore guest 
concentration between crystal replicates and asymmetric loading into the opposing faces of the 
same crystal may be explained by small differences in the free-solution concentration observed at 
each surface caused by imperfect external transport (e.g. due to irregularities in the agarose gel 
density) 
"! 2.5.3 Fit Experimental Data to Hindered Diffusion   




) cannot be directly determined from the Langmuir 
adsorption equilibrium constant (C
D
) obtained from the equilibrium adsorption isotherm. Instead, 
to decouple the time-lapsed confocal fluorescence signal into diffusive (mobile) and adsorbed 
(immobile) nanocluster pools and simulate adsorption-coupled diffusion, we used the Langmuir 
kinetic model combined with a one-dimensional pore diffusion equation (Eq. 2.9). To determine 
these parameters, the adsorption-coupled hindered diffusion model was fit using the sum of 
squared deviations integrated over time and position for three sets of confocal loading data 
gathered from three different crystals. The fixed parameters used in the model were either obtained 
from the adsorption experimental data, DLS measurements, or were calculated based on the known 





Figure 2.4. (A) Confocal images of Au25(GSH)18 nanocluster concentrations in free-solution: 0.0, 
0.5, 1.0, 2.0, and 4.0 mg/mL from left to right. (B.) Fluorescence standard created by averaging 
fluorescence intensities in A and converting to mol/mL. (C.) Processed loading data plotted as 
fluorescence intensity distributions at various time points. (D.) Example of symmetric 
concentration distribution data used to fit the hindered diffusion model; Intensity values from C 
were averaged across the central axis of symmetry (p 0 ruV), converted to units of concentration 
via the fluorescence standard, and corrected for scaffold-occluded volume by dividing by the CJ-
LPC void fraction of 0.476, which assumes unit cells with a volume of 1411.83 nm3 and a single 
ideal cylindrical nanopore with a radius of 13.0 nm and height of 5.058 nm.  
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 were found to be similar for all three crystals (Table 2.2, 




 parameters to simulate Au25(GSH)18 
nanocluster loading over the course of one hour with external concentration )
B
 = 1.43 x 10-7 
mol/mL. The resulting simulated concentration profiles combined both the adsorbed (*) and free 
()) concentrations and were in good agreement with the experimental observation (Figure 2.5). 
As transport progresses, the quantity of Au25(GSH)18 adsorbed to the pore wall increases towards 
an equilibrium maximum adsorbed state. The total amount of Au25(GSH)18 adsorbed at equilibrium 
is dependent on the free-solution concentration ()
B
) as can be seen in the equilibrium adsorption 
isotherm (Figure 2.2). Furthermore, as adsorption increases the pore diffusion coefficient ('
(
) 
decreases due to pore occlusion. Thus, under higher free solution concentrations, '
(
(*) will see 
greater attenuation. The results of simulating diffusion for 10 days using a high external 
concentration of 9.56 x 10-7 mol/mL (10 mg/mL) reveals a pore diffusion coefficient at the crystal 
surface that gradually dropped from 3.7 x 10-7 cm2/s to 3.4 x 10-10 cm2/s (Figure 2.6), which is far 
lower than the free-solution diffusion coefficient ('
B
 = 1.27 x 10-6 cm2/s). 
!! 2.6 CONCLUSIONS 
In summary, the investigation of Au25(GSH)18 nanocluster transport within CJ-LPC pores 
using confocal microscopy in combination with hindered diffusion simulation and adsorption 
equilibrium data can significantly advance the comprehension of macromolecular diffusion and 
adsorption in Large-pore protein crystal materials. The hindered diffusion simulation coincides 
well with confocal observation enabling kinetic parameters to be ascertained from the equilibrium 
adsorption data. This approach provides a suitable method to calculate the pore diffusion 























1 12.9 1.66 x 10-7 
2 13.2 1.70 x 10-7 
3 12.9 1.66 x 10-7 






Figure 2.5. (A, B) Concentration, distance, and time surface plots of the left-hand half (p 0 8 to 
p 0 ruV) of a 60-minute diffusion profile showing confocal data and FEM simulated data, 
respectively. (C.) Comparison of FEM data and experimental confocal data taken just inside the 
crystal at the surface (p 0 8) over 60-minutes, the model line represents the sum of ) and *. (D.) 
Comparison of FEM data and experimental confocal data taken at the 60-minute time point over 
the entire crystal (p 0 8 to p 0 y).  
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icts the pore causing an increase in hindrance effects which attenuate the pore diffusivity. We see 
a decrease in the pore diffusion coefficient over time as more nanoclusters adsorb and occlude the 
crystal pores thus hindering diffusion. This effect is maximized at higher free-solution 
concentrations that lead to a higher adsorbed state within the pores. These finding will benefit 
downstream efforts to better engineer large-pore protein crystal based nanoporous materials to 
serve as new and unique tools in bionanotechnology. 
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!! 2.8 TERM DEFINITIONS 
O):     Mobile phase concentration in pore (mol/mL) 
)
B




:    Effective concentration at the surface (mol/mL) 
'
3
:     Effective diffusion coefficient (cm2/s) 
'
(
:     Pore diffusion coefficient (cm2/s) 
'
B
:       Diffusion coefficient in free-solution (cm2/s) 
F
°:     Standard Gibbs free energy (kJ/mol) 
!
"
:     Adsorption coefficient (cm3/molO∙Os) 
!
#
:     Desorption coefficient (s-1) 
!
9
:     External mass transfer coefficient (cm/s) 
!
h
:     Boltzmann’s constant (1.3806 x 10-16 cm2 g/s2O∙OK) 
C
D
:     Langmuir adsorption equilibrium coefficient 
r:     Pore length (cm) 
m
n
:     Avogadro’s number (6.022 x 1023 mol-1) 
*:     Adsorbed concentration (mol/mL) 
*
9":








:     Initial pore radius (cm) 
I:     Au25(GSH)18 molecular radius (cm) 
J:     Adsorption temperature (K) 
P
z
:     Au25(GSH)18 molecular weight (10456 g/mol) 










CHARACTERIZING THE CYTOCOMPATIBILITY OF VARIOUS CROSS-LINKING 





!! 3.1 SUMMARY 
With rapidly growing interest in therapeutic macromolecules, targeted drug delivery, and in 
vivo biosensing comes the need for new nanostructured biomaterials capable of macromolecule 
storage and metered release that exhibit robust stability and cytocompatibility. One novel 
possibility for such a material are engineered large-pore protein crystals (LPCs). Here, various 
chemically-stabilized LPC derived biomaterials were generated using three cross-linking agents: 
glutaraldehyde, oxaldehyde, and 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide. LPC 
biostability and in vitro mammalian cytocompatibility was subsequently evaluated and compared 
to similarly cross-linked tetragonal hen egg white lysozyme crystals. This study demonstrates the 
ability of various cross-linking chemistries to physically stabilize the molecular structure of LPC 
materials—increasing their tolerance to challenging conditions while exhibiting minimal 
cytotoxicity. This approach produces LPC derived biomaterials with promising utility for diverse 
applications in biotechnology and nanomedicine. 
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!! 3.2 INTRODUCTION 
Protein crystals, typically evaluated solely for the elucidation of three-dimensional protein 
structure through X-ray diffraction, have unique chemical and material qualities—most notably, 
their self-assembling, homochiral, highly-ordered nanoporous structure. Intriguingly, the chemical 
properties of protein crystal materials can be readily engineered through genetic or chemical 
modification of their monomeric protein constituents. A common example of protein crystal 
modification involves the introduction of covalent bonds between adjacent monomers using 
bifunctional reagents.16 This chemical cross-linking has been shown to greatly improve overall 
crystal stability,15,17 thereby broadening the potential for protein crystals to be used in diverse 
material applications.26 
One distinct advantage of protein crystals over chemically synthesized nanoporous scaffolds, 
such as zeolites and metal organic frameworks, is their biological origin; biologically derived 
nanoporous materials have been recognized as attractive scaffolds for applications in which 
biodegradability and/or biocompatibility is preferred. Some of these applications include: drug 
delivery,81,169 vaccinations,99 environmental remediation,192 and biosensing.146–148 However, 
stabilizing biologically derived materials with chemical cross-linkers can lead to increases in 
cytotoxicity.31,38,193 Despite this risk, we are unaware of any studies that have quantified the 
cytotoxicity and stability of various chemically cross-linked protein crystal materials. Therefore, 
the extent of any toxic effects the cross-linking process may impart to protein crystal materials is 
unclear, nor is it clear whether the nanostructure of these biomaterials can survive in contact with 
living cells or tissues.  
To demonstrate the feasibility of utilizing chemically-stabilized protein crystal materials in 
biological and environmental applications in which both toxicity and material stability is a 
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concern, we investigated the efficacy of various cross-linking reagents to stabilize the molecular 
structure of two distinct protein crystal variants while minimizing cytotoxicity. The first crystal 
variant used in this study is a large-pore protein crystal (LPC) composed of CJ monomers (Figure 
3.1A & 3.1C). 
CJ is a modified form of a putative periplasmic isoprenoid binding protein derived from 
Campylobacter jejuni. Our lab has shown that CJ derived large-pore protein crystals (CJ-LPCs) 
have properties uniquely suited for programmable organization of macromolecular guests at 
distinct sites within hundreds of millions of precisely defined pores.50,79,80 The combination of high 
theoretical capacity for guest macromolecules and the mechanical strength of a cross-linked 
honeycomb lattice make CJ-LPCs attractive molecular depots for use in various biomedical and 
environmental applications. As a point of comparison, the second crystal variant studied was 
tetragonal hen egg white lysozyme (HEWL), which represents a more comprehensively studied 
protein crystal system with archetypal pore sizes (Figure 3.1B & 3.1D).   
!! 3.3 RESULTS AND DISCUSSION 
Large (100–500 µm diameter) CJ-LPCs were grown by sitting drop vapor diffusion at 20° C 
in 3.3–3.6 M (NH4)2SO4, 100 mM bis-tris at pH 7.0 (Figure 3.1C). Tetragonal HEWL crystals 
were grown per a modified version of a previously described batch crystallization protocol194 
(Figure 3.1D). Prior to cross-linking, crystals were washed in buffered high-salt solutions to 
remove residual protein monomers without compromising the integrity of the crystal. Washed 
crystals were then cross-linked using one of three chemical cross-linkers: 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC), glutaraldehyde (GA), or oxaldehyde (OA) to 
introduce covalent attachments between adjacent monomers, thereby generating various 






Figure 3.1. (A) CJ-LPC crystal lattice (PDB Code: 5W17) showing large (13 nm) pores. (B) 
Tetragonal HEWL crystal lattice (PDB Code: 2HTX) showing much smaller and more typical pore 
sizes (<2 nm). (C) CJ-LPCs in growth well. Scale bar: 200 µm. (D) HEWL crystals in growth 
well. Scale bar: 100 µm.  
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 ions intended to mimic the mother liquor to mitigate crystal degradation. Protein expression, 
purification, crystallization, and cross-linking are described in more detail in APPENDIX II.  
The efficacy of various cross-linking chemistries in stabilizing protein crystals on a 
macroscopic level was investigated using stereomicroscopy. Images were taken of crystals in high-
salt conditions directly after cross-linking (pre-incubation) and again after 24-hour incubation with 
adult human dermal fibroblast (HDFa) cells at 37° C (post-incubation). Pre-incubation images of 
cross-linked CJ-LPC materials (CJ/GA, CJ/OA, CJ/EDC) demonstrate similar macroscopic crystal 
quality as the washed non-cross-linked CJ-LPCs (CJ/NCL) (Figure 3.2A pre-incubation), thus 
indicating these cross-linking methods do not overtly lead to CJ-LPC deterioration. As expected, 
the comparatively low salt and high temperature environment associated with HDFa cell culture 
caused CJ/NCL crystals to completely dissolve within 24-hours. Conversely, all chemically 
stabilized CJ-LPCs continued to show no loss of crystal quality despite being transferred away 
from their high-salt crystallization environment (Figure 3.2A post-incubation). Therefore, all three 
cross-linking chemistries are shown to be independently sufficient and necessary to preserve the 
short-term macroscopic structure of CJ-LPCs in the presence of living cells. Complementary 
images of cross-linked HEWL crystals taken prior to incubation with HDFa cells reveal 
HEWL/GA crystals to have similar quality as the washed HEWL/NCL crystals; however, images 
of HEWL/OA and HEWL/EDC crystals show moderate to severe surface deformation and 
cracking (Figure 3.2B pre-incubation). Post-incubation images of HEWL/GA crystals continue to 
evince no loss of crystal quality while images of HEWL/OA reveal increased cracking and severe 
crystal deterioration—HEWL/EDC and HEWL/NCL crystals completely dissolved (Figure 3.2B 
post-incubation).  These  results  suggest  that  the  cross-linking  methods  for  HEWL/EDC  and   
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Figure 3.2. Microscopy images of protein crystals taken both before (pre-incubation) and after 
(post-incubation) 24-hour incubation with HDFa cells. (A) CJ-LPCs; Scale bar: 100 µm. (B) 
HEWL crystals; Scale bar: 50 µm. Note: ‘No Information’ indicates the crystals dissolved during 
incubation.  
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HEWL/OA were not sufficient to stabilize the macroscopic structure of tetragonal HEWL, 
resulting in severe crystal degradation and/or disintegration.  
To further examine cross-linked crystal stability, the molecular order of sufficiently cross-
linked protein crystal materials (CJ/GA, CJ/OA, CJ/EDC, HEWL/GA) was analyzed both pre- and 
post-incubation with HDFa cells by X-ray diffraction (XRD) on a Rigaku HomeLab (Figure 3.3). 
Pre-incubation CJ/OA and CJ/EDC crystals achieved diffraction out to approximately 3.7 and 3.1 
Å respectively, which is comparable to the washed pre-incubation CJ/NCL crystal diffraction of 
3.0 Å. Intriguingly however, while GA cross-linking did not overtly disrupt CJ-LPC crystal quality 
when observed on a macroscopic level via stereomicroscopy, it did disrupt the molecular order as 
observed by XRD; GA cross-linked CJ-LPCs demonstrated markedly reduced pre-incubation 
molecular order—to the point that the XRD data could not be comparatively indexed and scaled. 
These results indicate the molecular order of CJ/OA and CJ/EDC crystals was maintained 
throughout the cross-linking method, while GA cross-linked crystals became more disordered. 
Conversely, GA was the only cross-linking agent capable of stabilizing tetragonal HEWL crystals, 
both on a macroscopic level, as seen by stereomicroscopy, and on a molecular level, yielding a 
post-cross-linking diffraction resolution of 2.0 Å. 
To monitor short-term stability differences, the same cross-linked crystals were subsequently 
subjected to HDFa cell culture for 24 hours after which the post-incubation retention of molecular 
order was measured again using XRD. All cross-linked CJ-LPCs as well as the HEWL/GA crystals 
exhibited post-incubation resolution comparable to their respective pre-incubation resolution 
estimates (Figure 3.3 Table)—suggesting these cross-linked protein crystal materials can retain 
their molecular order in environments well outside their crystallization condition and in the 






Figure 3.3. Representative XRD diffraction patterns both pre- and post-incubation with HDF cells. Tables: High-resolution estimates 
for each diffraction set.  See APPENDIX II for XRD replicate data and resolution estimate details. Note: there is no resolution estimate 
for post-incubation NCL crystals due to the crystals dissolving when transferred outside their respective crystallization conditions. *The 
high-resolution estimate (>6.0 Å) for CJ/GA crystals is a qualitative estimate based on observable spots—the reflection data could not 
be comparatively indexed and scaled due to poor diffraction. 
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Potential cytotoxic effects from GA, OA, or EDC cross-linking was investigated by measuring 
the viability of HDFa and human macrophage (MV-4-11) cells when subjected to cross-linked 
protein crystal materials.  Prior to cross-linking and incubation with human cells, large CJ-LPCs 
and HEWL crystals were first fragmented by sonication to increase their surface area and thereby 
maximize the potential cytotoxic response195 (APPENDIX II). The particle size distribution of 
fragmented CJ-LPCs was observed via scanning electron microscopy (SEM). SEM images were 
processed using image stitching and particle detection packages in Fiji196,197 and quantified via 
histogram plotting tools in MATLAB version 9.1.0 (Natick, MA). The mean particle size was 
found to be 5.8 ± 3.9 µm with a mode of about 3.3 µm (APENDIX II Figure II.1).  
To prepare for incubation with HDFa cell culture, cross-linked fragmented protein crystal 
materials were sterilized in high-salt buffers containing 20% ethanol, washed in sterile PBS pH 
7.5, and transferred to sterile supplemented cell culture medium (APPENDIX II). HDFa cells were 
plated at a density of 150,000 cells/mL within a 96 well plate and allowed to adhere for 24 hours. 
After the initial 24-hour period, the old medium was evacuated and replaced with new 
supplemented medium containing the various fragmented protein crystal materials in a range of 
concentrations (1, 50, 100, 200, and 400 µg/mL) determined by Bradford assay. Cells were 
incubated in the presence of protein crystal materials for an additional 24 hours, after which, cell 
viability was measured using the PierceTM lactate dehydrogenase (LDH) cytotoxicity assay kit 
(Figure 3.4A & 3.4B). While HEWL/NCL sample wells maintained very high cell viability across 
all concentrations, HEWL/GA materials prompted a precipitous decline in cell viability 
corresponding to increasing material concentration—suggesting a toxic response to GA. Similarly, 
CJ/GA materials also triggered a dramatic decrease in cell viability corresponding to increasing 
material concentration. Conversely, CJ/OA, CJ/EDC, and CJ/NCL materials preserved cell viabil-  
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Figure 3.4. (A) HDFa cell viability under varying concentrations of fragmented HEWL protein crystal materials; Error Bars: standard 
deviation, n=3. (B)  HDFa cell viability under varying concentrations of fragmented CJ-LPC materials; Error Bars: standard deviation, 
n=3. (C) Control HDFa cells with no material added to the medium; Scale Bar: 300 !m; Top: green fluorescent live cell stain (calcein); 
Bottom: red fluorescent dead cell stain (ethidium homodimer). (D) HDFa cells incubated with 400 !g/mL CJ/EDC; Scale Bar: 300 !m. 
(E) HDFa cells incubated with 400 !g/mL CJ/OA; Scale Bar: 300 !m. (F) HDFa cells incubated with 400 !g/mL CJ/GA; Scale Bar: 
100 !m. (G) HDFa cells incubated with 400 !g/mL HEWL/GA; Scale Bar: 100 !m. 
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ity despite high material concentrations (up to 400 µg/mL). We suspect the slightly diminished 
viability seen in CJ/NCL sample wells compared to HEWL/NCL samples is due to trace quantities 
of endotoxin, which is progressively removed during CJ-LPC material purification, crystallization, 
and subsequent wash steps (APPENDIX II Figure II.3). The more pronounced reduction in cell 
viability for GA cross-linked crystals can likely be attributed to unreacted GA that has leached 
from the crystals into the growth medium. 
The HDFa viability quantified by LDH activity was qualitatively confirmed by live/dead 
staining (Figure 3.4C-3.4G); calcein (green) was used as the live cell stain while dead cells were 
visualized using ethidium homodimer (red). Control cells, not subjected to any materials, were 
compared to cells incubated with 400 µg/mL of various cross-linked protein crystal materials. The 
cell counts for control cells as well as cells incubated with CJ/EDC and CJ/OA crystals show 
minimal cell death, while cells incubated with CJ/GA and HEWL/GA materials appear to suffer 
approximately 50% cell death. These images agree with quantitative data from the LDH assay—
indicating minimal loss of cell viability for EDC and OA cross-linked protein crystal materials and 
a much higher loss of viability for protein crystal materials cross-linked by GA. More details 
concerning the LDH, endotoxin, and live/dead staining assays can be found in APPENDIX II.  
To prepare for incubation with MV-4-11 cell culture, cross-linked fragmented protein crystal 
materials were sterilized in high-salt buffers containing 20% ethanol, washed in sterile PBS pH 
7.5, and transferred to sterile double deionized water (APPENDIX II). Fragmented crystal 
materials were transferred to an empty 96-well plate at a concentration of 400 µg/mL and allowed 
to dry overnight. MV-4-11 cell suspension was then added to the dried material at a density of 
150,000 cells/mL. Cells were then incubated in the presence of the fragmented protein crystal 
materials for 24 hours, after which the cell viability (Figure 3.5A) and nitrite concentration was 
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determined (Figure 3.5B). The viability trend for MV-4-11 cultures is commensurate to HDFa 
cells, showing high viability for both NCL crystals as well as OA and EDC cross-linked protein 
crystal materials, while both CJ/GA and HEWL/GA materials engendered low cell viability. All 
samples tested demonstrated low nitrite concentration relative to the negative control (cells only), 
indicating these materials do not appear to promote human macrophage activation. 
!! 3.4 CONCLUSIONS 
A priori it was not known if chemically modifying CJ-LPC interfaces would substantially 
degrade diffraction quality. While GA, the cross-linking agent primarily used to stabilize protein 
crystals, generated robust CJ-LPCs on a macroscopic level when tested against HDFa cell culture, 
it exhibited the greatest initial loss in molecular order upon cross-linking. Migneault et al. details 
the complex solution properties of GA and lists 13 proposed forms ranging from monomeric to 
highly polymerized.28 Thus, in this case, the heterogeneous nature of GA is likely at odds with 
preserving molecular order at the lysine rich interfaces of CJ-LPCs. Surprisingly, the seldom used 
cross-linkers, OA and EDC, generated CJ-LPC materials capable of retaining molecular order 
post-incubation while suffering minimal loss of diffraction upon cross-linking. 
Conversely, cross-linking tetragonal HEWL with GA was shown to be effective at both 
stabilizing the crystal and preserving diffraction quality; these results support previous findings.29 
To date, neither OA nor EDC has been effective at stabilizing HEWL crystals. This is not 
surprising considering the small number of amines at HEWL crystal interfaces as well as a lack of 
proximal amine to carboxylic acid pairs at crystal interfaces. OA is the shortest dialdehyde and 
primarily monomeric, which may limit its ability to be effective.198 In this case, the ability to 




Figure 3.5. (A) MV-4-11 cell viability when incubated with various protein crystal materials at a 
concentration of 400 !g/mL; Error Bars: standard deviation, n=3. (B) Nitrite concentration 
released from MV-4-11 cells incubated with 400 !g/mL of various protein crystal materials.; Error 
Bars: standard deviation, n=3. 
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The results of the stability and toxicity tests suggest that both OA and EDC cross-linked CJ-
LPC materials are superior to protein crystals cross-linked by GA, demonstrating both promising 
molecular stability and cytocompatibility when tested in the short-term against HDFa and MV-4-
11 cells. These materials may be particularly well suited for use in biocatalysis, drug delivery, 
biosensing, and environmental remediation. Further genotoxicity, and immunogenicity studies 
should be done to determine long-term biocompatibility toward a more diverse set of tissue types. 
By pursuing this research, we hope to better understand protein crystal materials and leverage that 
knowledge to design advanced nanostructured devices for applications in biotechnology and 
nanomedicine. 
!! 3.5 RECOGNITION 
The authors would like to thank Morgan Hawker for her aid in SEM training, Aidan Friederich 
for assistance with the LDH cytotoxicity assay, and finally Matt Kipper, Ellen Fisher, and Ketul 
Popat for thoughtful discussion. This research was supported in part by the Compatible Polymer 
Network project funded by the Colorado State University Office of the Vice President for Research 
and by the National Science Foundation grant number 1506219. The authors declare no competing 




TEXTILE FUNCTIONALIZATION BY POROUS PROTEIN CRYSTAL 




!! 4.1 SUMMARY 
Protein crystals are versatile nanostructured materials that can be readily engineered for 
applications in nanomedicine and nanobiotechnology. Despite their versatility, the minute size of 
individual protein crystals presents challenges for macroscale applications. One way to overcome 
this limitation is by immobilizing protein crystals onto larger substrates. Cotton is composed 
primarily of cellulose, the most common natural fiber in the world, and is routinely used in 
numerous material applications including textiles, explosives, paper, and bookbinding. Here, 
HEWL and CJ protein crystals were conjugated to the cellulosic substrate of cotton fabric using a 
1,1'-carbonyldiimidazole/aldehyde mediated coupling protocol. The efficacy of this attachment 
was assessed via accelerated laundering and quantified by fluorescence imaging. The ability to 
load guest molecules of varying sizes into the scaffold structure of the conjugated protein crystals 
was also assessed. This work demonstrates the potential to create multifunctional textiles by 
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!! 4.2 INTRODUCTION 
Protein crystal materials are alternative porous scaffolds to traditional non-biological 
nanoporous materials such as zeolites or metal organic frameworks (MOFs). Efforts to characterize 
protein crystals have led to advancements in crystal production, stabilization, and design—
increasing their appeal for material applications. Protein crystal materials are attractive for many 
reasons: they are self-assembling, exhibit a highly ordered porous structure, have been shown to 
be biodegradable and biocompatible,32,109 and can be engineered with relative ease through genetic 
modification or chemical conjugation. Protein crystal materials have been utilized in a variety of 
disciplines for various applications ranging from biocatalysis15,120–128 and chromatography4,199,157–
160 to drug delivery81,114,108,39 and biosensing.146–148,155 Here, we propose implementing protein 
crystals as tunable porous scaffolds for the organization and containment of diverse functional 
guest molecules in the interest of producing multifunctional textile materials.  
A typical protein crystal contains uniform solvent-filled channels ranging from 30 to 60% of 
the total crystal volume.3 These pores can be employed as a reservoir for guest molecules of 
assorted size and functionality, including various small molecules, enzymes, therapeutic proteins 
and DNA, as well as nanoparticles and organometallic compounds. Despite their remarkable 
qualities, usage of protein crystals in conventional macroscale material science applications is 
limited due to their small size (commonly <1 mm). This limitation may be overcome by devising 
methods for integrating protein crystals into larger host materials. Textiles are inexpensive and 
widely used across many industries, making them attractive host materials for protein crystal 
bioconjugation. By conjugating crystals to textiles, a multifunctional macroscale nanoporous 
scaffold material can be realized. 
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We investigated two distinct protein crystal variants each with dramatically different pore size 
distributions, geometries, and lumenal environments. The first crystal variant tested was tetragonal 
hen egg white lysozyme (HEWL), a relatively inexpensive and well characterized protein (Figure 
4.1A). Cvetkovic et al. determined that the pores of cross-linked tetragonal HEWL crystals accept 
small molecule guests with molecular weights below 1,000 g/mol.47–49 In contrast, CJ protein 
crystals, our second crystal variant, are a member of the large-pore protein crystal (LPC) class—
possessing axial pores measuring 13 nm in diameter which enables the accommodation of 
macromolecular guests (Figure 4.1B). Typical CJ derived large-pore protein crystals (CJ-LPCs) 
possess hundreds of millions of pores and can be engineered with capture sites within the lumen 
for the purpose of organizing macromolecular guests at distinct sites.50,79,80,5 The combination of 
high theoretical capacity for guest molecules and the mechanical strength of cross-linking make 
porous protein crystals attractive molecular depots for use in multifunctional macroscale 
nanoporous scaffold materials. 
!! 4.3 RESULTS AND DISCUSSION 
To demonstrate the feasibility of attaching protein crystals to textiles via chemical conjugation, 
we first investigated the retention properties of two conjugation strategies designed to link primary 
amine groups on HEWL crystals to cellulose fibers within 100% cotton fabric. Small (10 – 100 
µm diameter) tetragonal HEWL crystals were grown per a modified version of a previously 
described batch crystallization protocol.194 Prior to cross-linking, crystals were washed in buffered 
high-salt solutions to remove residual protein monomers without compromising the integrity of 
the crystals.  
Washed crystals were then stabilized via cross-linking by direct addition of glutaraldehyde (GA), 







Figure 4.1. (A) Cross-linked tetragonal HEWL crystal lattice (PDB Code: 2HTX) showing small 
archetypal protein crystal pore sizes (<2 nm) which can accommodate small molecules such as 
sulforhodamine 101. (B) CJ-LPC crystal lattice (PDB Code: 5W17) showing much larger (13 nm) 
pores which can accommodate macromolecular guests such as cytochrome P450 heme domain 
(PDB Code: 2HPD).  
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scaffold. To reintroduce amines to the crystal surface, GA cross-linking intermediates were 
quenched with carbohydrazide. Finally, crystals were trace labeled with NHS-fluorescein. Refer 
to APPENDIX III for more details concerning HEWL crystallization and cross-linking. 
Fabric activation was achieved by introducing carboxylic acid groups onto cellulose fibers 
within the cotton fabric using a sodium hypophosphite and citric acid (CA) treatment adapted from 
previous methods developed by Edwards et al.34,35 (Figure 4.2A). Oxidized cotton was then 
incubated with 1,1’-carbonyldiimidazole (CDI) in a non-aqueous environment as detailed by 
Hermanson;19 this process formed an intermediate allowing for direct chemical attachment of 
amine containing substituents to the textile surface. From this CDI intermediate, short-length 
attachment (CDI-only) was achieved by direct addition of protein crystals to the textile (Figure 
4.2B). Alternatively, to form a somewhat extended molecular interface for crystal attachment, 
CDI-intermediate textile was treated with adipic acid dihydrazide (AAD). Long-length attachment 
(CDI+AAD+GA) to the textile was therefore achieved by cross-linking the primary amine from 
the AAD treated textile to the protein crystal using GA (Figure 4.2C). Fabric treatment, and HEWL 
attachment protocols are described in more detail in APPENDIX III 
The effectiveness of the CDI-only and CDI+AAD+GA conjugation schemes was assessed 
using an accelerated laundering protocol based on the American Association of Textile Chemists 
and Colorists (AATCC) Test Method 61 section 1A.200 Standard 1”x1” cotton test fabric swatches 
containing five evenly distributed areas (~12 mm diameter, Figure 4.3A) of attached protein crystal 
material were subjected to a total of 60 minutes of wash time in an accelerated laundering machine. 
HEWL crystal retention was quantified every 15 minutes by removing the samples and imaging 
them on a Typhoon FLA 7000 fluorescent scanner using an excitation wavelength of 473 nm at 






Figure 4.2. Protein crystal to fabric attachment chemistries. (A) Formation of surface carboxylic 
acid groups on cellulose fabric. (B) Formation of CDI intermediate and crystal attachment via pre-
existing primary amines on the crystal surface. (C) Attachment of AAD linker arm to CDI 








Figure 4.3. Results of the accelerated wash tests. (A) Cotton test swatch containing 5 areas of HEWL crystal attachment at time zero in 
the accelerated wash protocol.; Inset: magnified view of the center application area demonstrating fluorescent puncta used to normalize 
the percent retention of protein crystals throughout the wash cycles. (B) Comparison of short-length and long-length attachment reaction 
schemes for HEWL crystals over 60 minutes of accelerated laundering time; Error Bars: standard deviation, n=5. (C) Comparison of 
GA and OA cross-linked CJ-LPC retention over 60 minutes of accelerated laundering time; Error Bars: standard deviation, n=5.
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fluorescent puncta corresponding to retained trace-labeled crystals. In initial testing using HEWL 
crystals, the CDI+AAD+GA conjugation scheme performed significantly better than that of the 
CDI-only treatment (Figure 4.3B). Approximately 40% of HEWL crystals were retained on 
CDI+AAD+GA treated fabric, while just over 20% of HEWL crystals were retained on CDI-only 
treated fabric after one hour of accelerated laundering. In contrast, control swatches that either 
were not decorated with carboxylic acid groups or did not receive CDI showed near-zero crystal 
retention after rinsing in pure H2O (APPENDIX III Figure III.3). These results suggest that the 
fabric activation by CA treatment is necessary for CDI installment of protein crystals. We 
hypothesize that the increased linker arm length created by the addition of AAD and GA results in 
a greater number of covalent bonds across the crystal-to-fabric interface, thereby improving overall 
retention. Because the CDI+AAD+GA treatment showed a marked improvement over CDI-only, 
the former was chosen as the preferred method for testing CJ-LPC attachment. However, it has 
previously been shown that oxaldehyde (OA) cross-linked CJ crystals retain diffraction better than 
crystals cross-linked with GA.50 In light of this, OA cross-linked crystals and a final 
CDI+AAD+OA conjugation step were implemented alongside GA treatments for CJ-LPC 
attachment tests.  
Small (10 – 100 µm diameter) CJ-LPCs were grown by batch crystallization in 3.4-3.6 M 
(NH4)2SO4, 40 mM bis-tris pH 6.5 at 15º C. Crystals were cross-linked with either GA or OA, 
quenched with carbohydrazide, and trace labeled with NHS-fluorescein implementing the same 
procedures used for tetragonal HEWL crystals. After cross-linking, crystals were conjugated to 
the cotton fabric either by a CDI+AAD+GA scheme or CDI+AAD+OA scheme. CJ protein 
expression, purification, crystallization, fabric treatment, and cross-linking methods are detailed 
in APPENDIX III. As with HEWL, approximately 40% of CJ-LPC crystals were retained on 
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CDI+AAD+GA treated fabric after one hour of accelerated laundering (Figure 4.3C). However, 
this retention rate dropped slightly to 35% for OA cross-linked CJ-LPC crystals on 
CDI+AAD+OA treated fabric. We suspect that this discrepancy is caused by GA’s propensity for 
polymerization.28 Polymerization of GA between the AAD primary amines and the CJ-LPC 
primary amines may result in longer conjugation linkages than theorized in Figure 4.2C thus 
providing a more extensively bonded crystal-to-fabric interface  when compared to a similarly 
structured bifunctional cross-linking agent such as OA. 
After successful demonstration of attachment, protein crystal conjugated cotton was loaded 
with guest molecules of varying sizes to demonstrate the wide range of guest functionalization. 
Separate fabric swatches containing either CDI+AAD+GA conjugated HEWL crystals or 
CDI+AAD+GA conjugated CJ crystals were first washed for 15-minutes in pure water to remove 
excess non-covalently attached crystals from the fabric surface. Cotton samples conjugated with 
HEWL crystals were added to 500 µL sulforhodamine 101 (Figure 4.1A) in a sealed vessel and 
incubated for 24 hours protected from light. After incubation, the fabric was briefly rinsed with 
pure water to remove residual guest molecules. Differential interference contrast (DIC) and 
fluorescent (488 nm & 561 nm) confocal images taken both before and after incubation with 
sulforhodamine 101 demonstrate HEWL crystal attachment and co-localization with the small 
molecule guests (Figure 4.4A). Similarly, CJ-LPC conjugated fabric was soaked in 500 µL of 
sulforhodamine-labeled cytochrome P450 heme domain to demonstrate the potential for enzyme 
loading. The cytochrome P450 heme domain used as a model guest enzyme was a synthetic 
homolog to the soluble P450s of Bacillus megaterium and Bacillus subtilis.201 Specifically, we 
used a purified aliquot of chimera 21311331,  where each numeral  indicates the parent enzyme  




Figure 4.4. Composite confocal images of protein crystals conjugated to cotton fabric (DIC, 
488nm and 561nm). (A) Left: empty fluorescein-labeled HEWL crystals (green). Right: HEWL 
crystals (green) after 24-hour incubation with sulforhodamine 101 (red). (B) Left: empty 
fluorescein-labeled CJ-LPCs (green); Right: CJ-LPCs (green) after 36-minute incubation with 
sulforhodamine-labeled P450 (red).  
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confocal microscope at 488 nm and 561 nm every 2 minutes for 36 minutes (APPENDIX III Figure 
III.4). Diffusion of P450 enzyme into CJ-LPC pores was observed throughout this time-lapse. 
After loading, the fabric was briefly rinsed with pure water to remove residual P450 enzyme. DIC 
and fluorescent (488 nm & 561 nm) confocal images were then taken, demonstrating CJ-LPC 
attachment and co-localization with the macromolecular guests (Figure 4.4B). These results 
indicate that a range of guest molecules can be loaded into different porous protein crystal scaffolds 
that have been conjugated to cellulose fibers in cotton textiles. More information regarding guest 
loading can be found in APPENDIX III. 
!! 4.4 CONCLUSIONS 
The myriad topologies of protein crystals provide a wide range of pore structures and 
dimensions. As such, these materials can accommodate adsorbates of varying size, from small 
molecules to macromolecular guests. Here we have demonstrated that versatile guest molecule 
storage materials may be created from inexpensive cotton fabrics functionalized by conjugated 
protein crystals. There is a clear separation of timescales in guest retention between the bare textile 
and the protein crystal reservoirs, with reservoirs achieving superior retention. Furthermore, the 
loading times required for each guest molecule depends on the host crystal. By rationally selecting 
the host crystal pore structure, one could conceivably optimize the storage or transport kinetics of 
guest molecules based on size, charge, or hydrophobicity. Furthermore, multi-species guest 
loading and release may be possible by conjugating a variety of protein crystal reservoirs, each 
optimized for a specific guest molecule.  
This method of loading guest molecules into the void space of protein crystals conjugated to 
textiles may prove a reliable method for the extended, metered release of a variety of molecules. 
We have previously demonstrated guest molecule release in response to changes in pH;79,80 thus, 
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it may be feasible to trigger release of guest molecules from textile bound protein crystal reservoirs 
using environmental cues such as pH or exposure to analytes. Characterizing guest loading and 
release kinetics under varying environmental conditions may be an attractive follow up study. 
Applications of this technology range from medical wound dressing to multifunctional textiles 
exhibiting anti-microbial and anti-malarial properties. 
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!! 5.1 SUMMARY 
Nanostructured devices of the future will improve upon existing technology in numerous 
regards, incorporating multiple components into smaller, integrated devices that are sufficiently 
economical, robust, and biodegradable. Porous protein crystals are unique materials that may be 
used as novel nanostructured host-guest devices. The stability, long-term biodegradability, and 
small size of cross-linked porous protein crystals could enable otherwise infeasible applications in 
biosensing, drug delivery, biotemplating and catalysis—providing new tools for the advancement 
of human health and technology. The work presented in this dissertation helps demonstrate the 
application potential of porous protein crystal based host-guest nanostructured systems; we not 
only made steps toward better understanding host-guest biochemical interactions and transport 
dynamics, but also made progress in characterizing the biocompatibility, physical stability, and 
chemical versatility of these materials and their guest molecules.  
Typical pore diameters of protein crystals have been reported to range from 0.3 – 10.0 nm.3 
However, we demonstrate here a recently identified class of porous protein crystals exhibiting pore 
diameters greater than 10 nm. These large-pore protein crystals (LPCs) are capable of 
macromolecular uptake, allowing them to be used as novel host scaffolds. The primary protein 
crystal used in this study was composed of CJ monomers, a modified form of a putative 
periplasmic isoprenoid-binding protein derived from Campylobacter jejuni. CJ derived large-pore 
protein crystals (CJ-LPCs) exhibit an axial pore diameter of 13 nm and less than 3 nm diameter 
lateral pores. The aim of this dissertation work was to provide foundational data that will improve 
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our understanding of host-guest transport phenomena within these unique LPC materials as well 
as characterize their chemical versatility, physical stability, and biological compatibility with 
respect to other more archetypal protein crystal scaffolds, such as tetragonal HEWL. By pursuing 
this research, we hope to better understand LPC materials and leverage that knowledge to 
intelligently design advanced nanodevices for use in medicine and biotechnology.  
"! 5.1.1 Improving Techniques for the Study of Adsorption-Coupled Diffusion within the 
Confined Pores of Protein Crystal Materials 
We developed methods for quantifying hindered diffusion of Au25(glutathione)18 nanoclusters 
in the presence of strong adsorption within an LPC pore environment. This was achieved by first 
determining the equilibrium adsorption coefficient by performing constant volume bulk 
equilibrium adsorption experiments. Next, we monitored macromolecular Au25(GSH)18 
nanocluster transport within CJ-LPC pores using confocal microscopy. In our confocal loading 
studies, we observed a decrease in the pore diffusion coefficient over time as more nanoclusters 
adsorb and occlude the crystal pores, thus hindering diffusion. This effect was maximized at higher 
free-solution concentrations, which lead to a higher adsorbed state within the pores. We developed 
a hindered diffusion simulation model that coincides well with our transport observations. This 
model enabled kinetic parameters to be ascertained from equilibrium adsorption data, providing a 
suitable method to calculate transport phenomena involving adsorption-coupled diffusion whereby 
the adsorbate constricts the pore causing an increase in hindrance effects which attenuate the pore 
diffusivity. These finding may benefit downstream efforts to better engineer large-pore protein 
crystal based nanoporous materials to serve as new and unique tools in bionanotechnology. 
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"! 5.1.2 Understanding the Effects of Various Cross-linking Chemistries on Protein Crystal 
Stability and Biocompatibility 
To demonstrate the feasibility of utilizing chemically-stabilized protein crystal materials in 
biological and environmental applications in which both toxicity and material stability is a 
concern, we investigated the efficacy of various cross-linking reagents to stabilize the molecular 
structure of two distinct protein crystal variants (tetragonal HEWL and CJ-LPC) while seeking to 
minimizing cytotoxicity. We crosslinked HEWL crystals and CJ-LPCs with glutaraldehyde (GA), 
oxaldehyde (OA), and 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). The retention of 
molecular order of these materials was investigated using X-ray diffraction both after cross-linking 
and after incubation with adult human dermal fibroblast (HDFa) cells. While GA has been widely 
shown to stabilize HEWL crystals without loss in diffraction,29 it was not initially known if 
chemically modifying CJ-LPC interfaces would substantially degrade diffraction quality. While 
GA, the cross-linking agent primarily used to stabilize protein crystals, generated robust CJ-LPCs 
on a macroscopic level when tested against HDFa cell culture, it exhibited the greatest initial loss 
in molecular order upon cross-linking. We hypothesized that, in this case, the heterogeneous nature 
of GA28 was likely at odds with preserving molecular order at the lysine rich interfaces of CJ-
LPCs. Surprisingly, the seldom used cross-linkers, OA and EDC, generated CJ-LPC materials 
capable of retaining molecular order while suffering minimal loss of diffraction upon cross-linking 
and incubation with human cell culture. 
Potential cytotoxic effects from GA, OA, or EDC cross-linking was investigated by measuring 
the viability of HDFa and human macrophage (MV-4-11) cells when subjected to cross-linked 
protein crystal materials. Cells were incubated in the presence of protein crystal materials for 24 
hours, after which, cell viability was quantified by monitoring lactate dehydrogenase activity. 
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While non-cross-linked crystal materials maintained very high cell viability across all 
concentrations, GA cross-linked HEWL and CJ-LPC materials prompted a precipitous decline in 
cell viability corresponding to increasing material concentration—suggesting a toxic response to 
GA. Conversely, OA and EDC cross-linked CJ-LPC materials preserved cell viability despite high 
material concentrations (up to 400 µg/mL). The more pronounced reduction in cell viability for 
GA cross-linked crystals can likely be attributed to unreacted GA species that had leached from 
the crystals into the growth medium.  
The results of the stability and toxicity tests suggest that both OA and EDC cross-linked CJ-
LPC materials are superior to protein crystals cross-linked by GA, demonstrating both promising 
molecular stability and cytocompatibility when tested in the short-term against HDFa and MV-4-
11 cells. These materials may be particularly well suited for use in biocatalysis, drug delivery, 
biosensing, and environmental remediation. Further genotoxicity, and immunogenicity studies 
should be done to determine long-term biocompatibility toward a more diverse set of tissue types. 
"! 5.1.3 Assessing Bioconjugation Techniques for the Immobilization of Protein Crystal 
Reservoirs for the Production of Multifunctional Materials 
We demonstrated that the pores or protein crystals can be employed as a reservoir for guest 
molecules of assorted size and functionality. This work suggests that these materials may have the 
potential to retain various small molecules, enzymes, therapeutic proteins and DNA, as well as 
nanoparticles and organometallic compounds. Historically, despite their remarkable qualities, 
usage of porous protein crystals in conventional macroscale material science applications has been 
limited due to their small size (commonly <1 mm). Here, we presented methods to overcome this 
limitation by integrating protein crystals into larger, inexpensive textile host materials.  
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Tetragonal HEWL crystals and CJ-LPCs were conjugated to the cellulosic substrate of cotton 
fabric using a carbodiimide-mediated coupling reaction. The efficacy of this attachment was 
assessed via accelerated laundering and quantified by fluorescence imaging. The ability to load 
guest molecules of varying sizes into the scaffold structure of the conjugated protein crystals was 
also assessed. This work demonstrates engineered LPC materials to be attractive candidates for 
the uptake, immobilization, andcontrolled release of macromolecular guests making them 
promising targets for use as nanostructured scaffolds. By conjugating crystals to textiles, 
multifunctional macroscale nanoporous scaffold materials can be realized which may be uniquely 
suited for applications in wound dressing and textile science.  
!! 5.2 FUTURE PROSPECTIVE 
"! 5.2.1 DNA Guest Molecule Loading for Information Storage 
The work in this dissertation illustrates the propensity for large-pore protein crystals, such as 
CJ-LPCs, to accommodate macromolecular guest molecules within their interior void spaces either 
through passive diffusion or adsorption. This feature may be exploited for various applications in 
guest molecule storage. Recent unpublished results provide a proof-of-principle for loading protein 
crystals with short, exogenous oligonucleotides. Confocal microscopy was used to observe the 
transport and adsorption of 6FAM-labeled 15-mer DNA to the interior of oxaldehyde (OA) cross-
linked CJ-LPCs. Remarkably, preliminary results indicate guest DNA remains adsorbed in a wide 
variety of conditions including high salt aqueous solutions and aqueous-organic DMSO solutions. 
(data not shown). Further research is needed to determine the reproducibility of these results and 
to optimize experimental loading and unloading conditions. It will be important to quantify the 
adsorption capacity of CJ-LPCs and to determine if there are size limitations for the guest DNA. 
We will additionally evaluate the resulting host-guest crystals for information storage and 
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barcoding applications—assessing the propensity of the host crystals to protect guest DNA under 
challenging conditions (i.e. from degradation in the environment). To these ends, a recent member 
of the Snow lab, Julius Stuart, will conduct additional confocal microscopy and adsorption 
isotherm experiments with fluorescently labeled oligonucleotides of varying size in a wide range 
of solution conditions. Microscopic information repositories such as this may have a variety of 
long-term analytical, forensic, and environmental applications. 
"! 5.2.2 Crystal Functionalization by Covalent Guest Capture 
Our lab has recently shown the ability to install small molecule guests onto the pore surface of 
CJ-LPCs  by  way  of  engineered  solvent-exposed  cysteine  residues.5 This covalent  guest capture 
could be used to add novel functionality to host crystals by enabling site-specific modification of 
the lumenal environment.  
Lanthanide Complex Assembly and Capture: Our collaborators in China have recently 
published work on the assembly of lanthanide complexes within cross-linked hen egg white 
lysozyme (HEWL) crystals.138 This research was conducted in the interest of next-generation 
photonic applications; the authors claim organized arrays of lanthanide complexes to be 
compelling design targets for a variety of reasons: i) unlike other metals, lanthanides can provide 
unique photophysical properties to a material, depending on their coordination sphere. Long-lived 
luminescence from lanthanide centers can compete favorably with the properties of fluorescent 
proteins or small molecules; ii) incorporation into porous scaffolds, such as protein crystals, would 
result in a three-dimensional array of emitters, which should ultimately allow superior performance 
compared to uncontrolled lanthanide complex aggregates; iii) the photophysical properties of the 
resulting lanthanide lattice may be improved by the detailed structure of the crystal host scaffold, 
thereby enabling a new class of sensors in which the long-lived luminescence of the lanthanide 
! 92!
sites can be used to eliminate background; iv) as heavy atoms, lanthanide sites will be easy to 
validate via single-crystal X-ray diffraction. However, one limitation facing this technology is the 
slow leakage of lanthanides from the HEWL crystal scaffold (i.e. limited capture capability). To 
address this issue, it may be advantageous to install chemical groups, such as phenanthroline, that 
are capable of coordinating lanthanides at specific locations within an LPC environment thereby 
facilitating lanthanide retention and a longer luminescent lifetime of the material. 
Nitric Oxide Releasing Protein Crystal Materials: In addition to lanthanide-based photonic 
applications, small molecule capture could provide advancements in drug delivery. For instance, 
nitric oxide (NO) is a cell signaling gas with many therapeutic uses including antimicrobial and 
anticancer properties.110,111 As such, NO-releasing materials have garnered increasing interest for 
medicinal applications.202 Melissa Reynolds’ group here at Colorado State University has 
demonstrated sustained NO-release from an S-nitrosothiol-based bioerodible coating and 
produced metal-organic frameworks (MOFs) capable of catalyzing NO-production from 
endogenous S-nitrosothiols.203,204 S-nitrosoglutathione (GSNO), is an S-nitrosothiol with 
remarkably high NO retention leading to steady, long-term NO release when compared to other S-
nitrosothiols such as S-nitrosocysteine.205,206 Engineered CJ-LPCs could conceivably be 
functionalized with GSNO molecules by way of cysteine capture sites to produce a novel NO-
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ADSORPTION-COUPLED DIFFUSION OF GOLD NANOCLUSTERS WITHIN A LARGE-




!! I.1 PORE VOLUMES AND NUMBER OF NANOCLUSTERS PER UNIT CELL  
 
Considering the known crystalline nanostructure of CJ-LPC pores, the Langmuir isotherm 
seems to be a reasonable choice. The periodicity of the crystal increases the realism of the 
Langmuir assumption that the binding sites are equivalent. Also, the Langmuir isotherm capacity 
of a single adsorption monolayer is fairly realistic, in that the nanopores could not physically 
accommodate more than 2 layers for guests with a diameter of ~3 nm, and the formation of such a 
second layer would prevent further transport into the crystal (Figure I.1). Additionally, the 
volumetric capacity of a hypothetical second layer would be reduced. Specifically, the volume of 
the outer ~3 nm shell would be ℎ" 6.5& − 3.5&  = 477 nm3, while the second shell would only be 
ℎ" 3.5& − 0.5&  = 191 nm3, or only 40% of the capacity of the outer layer before taking into 
account discrete particle effects. 
Analytical lower bound: hard spheres in a hard cylinder: 
 
We can provide an analytical lower bound for the maximum capacity of the adsorbed nanocluster 
layer if we consider Au25(GSH)18 nanoclusters to be hard spheres with a diameter of 3.08 nm 
(HYDROPRO1 prediction) and the pores to be hard cylinders of diameter 13.0 nm: 








  (Eq. I.1) 
Where A is the packing fraction, ℎ is the height of the unit cell (5.0577 nm), KLM is the initial pore 
radius (6.5 nm) and R is the radius of a Au25(GSH)18 nanocluster (1.54 nm). Therefore, the right-


























Figure I.1. Diagram demonstrating the Au25(GSH)18 adsorption layers within a single pore of 
CJ: a 1 nm disc, inscribed within a 7 nm disc, inscribed within a 13 nm disc. 
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while the denominator corresponds to the volume of a Au25(GSH)18 nanocluster sphere 
(NXYGZ [\] ^_). Thus, Equation A1.1 can be written as: 
*+,-*.*/#/1.&2 345 67/-8/9-:;</=+>?: = A
`abcde/fghic
`jkGZ lmn ^_
   (Eq. I.2) 
If we use the maximum 3-dimensional packing fraction for spheres of 0.74 we find the maximum 
number of Au25(GSH)18 nanoclusters in the first adsorbed layer to be approximately 23. If we use 
a more conservative 2-dimensional hexagonal packing fraction of 0.60 (subtracting 1/6th of the 
volume for three spheres inset on an equilateral triangular prism, see Figure I.2), we obtain a 
modest 19 nanoclusters per unit cell. Both estimates appear to underestimate the number of 
nanoparticles that can adsorb to the crystal. However, as outlined below, a single adsorption layer 
is still consistent with the data. 
Numerical estimate for adsorbed layer volume: To more accurately estimate the volume 
that is accessible to the nanoclusters in the pores, and adsorbed to the scaffold crystal, we turn to 
numerical estimates. By explicitly modeling possible nanocluster binding, and quantifying 
accessible volume elements using a grid (see Kowalski et al. Supporting Information)2 we observe 
that the ideal 13 nm diameter cylinder underestimates the volume available for nanocluster 
occupancy. In Figure I.3, we use orange spheres to mark grid points that are accessible to some 
portion of Au25(GSH)18 nanoclusters, when such nanoclusters are docked throughout the protein 
matrix. Numerically, the adsorbed layer volume is approximately 563 nm3, 18% larger than the 
idealized outer cylindrical shell. 
Numerical estimate for nanocluster volume: We can additionally use numerical methods to 
more accurately assess the volume consumed per nanocluster. To estimate the nanocluster volume 
we used the software package MSMS.3 With default atomic radii, and a solvent probe radius of 















Figure I.2. Diagram demonstrating 2-dimensional hexagonal packing fraction of 0.6, a value 







Figure I.3. Diagram demonstrating that the ideal 13 nm diameter cylinder (purple circle) assumed 
for CJ-LPC pores underestimates the total volume available for nanocluster occupancy. Orange 
spheres mark grid points that are accessible to some portion of Au25(GSH)18 nanoclusters; 
numerically, the adsorbed layer volume is approximately 563 nm3 or 18% larger than the idealized 
outer cylindrical shell. 
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ated surface mesh. A sphere with this volume has a radius of only 1.13 nm. Figure I.4 shows the 
triangulated surface mesh for Au25(GSH)18, and a comparison between the atomic coordinates for 
Au25(GSH)18 and a sphere of the same net volume (radius=1.13 nm). 
Maximum observed packing fraction: To estimate the actual packing fraction (A), we use 
the numerical estimate for the maximum adsorbed layer volume (NOPQRS/TUVWQ) of 563 nm
3 per unit 
cell and the numerical minimum excluded volume per nanocluster (NXYGZ [\] ^_) of 6.05 nm
3, and 
the experimentally observed maximum concentration of adsorbed nanoclusters of ~29 per unit cell. 
Solving for A in Equation I.2, we obtain a packing fraction of only 0.31, well under the theoretical 
maximum of 0.6 for a hexagonally close-packed sphere monolayer (see above).  
Implied inter-nanocluster spacing for maximum adsorbed layer: If we assume that 29 
guest nanoclusters are arranged in a typical unit cell (opUq), then the portion of the adsorbed layer 
volume available for a typical nanocluster would be 19.4 nm3. If we model the packing 
arrangement as a hexagonal monolayer (packing fraction of 0.6), we can imagine individual 
nanoclusters as spheres of 11.65 nm3 with inter-molecule spacing of 2.8 nm. Figure I.5, shows an 
image of two Au25(GSH)18 nanoclusters, with a 2.8 nm displacement. This level of spacing appears 
to be sufficient for the adsorbed layer to retain solvent (and counterions) between the nanoclusters.  
!! I.2 EXTERNAL FREE-SOLUTION CONCENTRATION AT THE BOUNDARY  
Au25(GSH)18 nanoclusters are added to the upper well of a the microwell chip (Figure I.6) at a 
known concentration (rM). However, Au25(GSH)18 nanoclusters must diffuse through some 
distance (,) of low percentage agarose gel separating the upper well from the confocal plane 






Figure I.4. Diagram demonstrating the structural volume of Au25(GSH)18. (Left) Triangulated 
surface mesh for Au25(GSH)18. (Right) Comparison between the atomic coordinates for 
Au25(GSH)18 and a sphere of radius 1.13 nm, which equates to the numerically estimated solvent 
excluded volume of 6.05 nm3. 
 
 
Figure I.5. Diagram of two Au25(GSH)18 nanoclusters displaced by 2.8 nm, blue circles 


































Figure I.6. Schematic illustration of the microwell chip used for confocal imaging (not to scale). 
The crystal is immobilized in the lower well (2 µL volume) using 0.4% low melting point agarose 




solution at the boundary is lower than rM and can be approximated using the error-function 
compliment for a semi-infinite medium:4  
rMi < = rM?:9s
q
& tFS
          (I.3) 
Where rMi is the effective free-solution concentration at the boundary at any given time, <, and is 
used in the boundary conditions (CHAPTER 2 Eq. 2.10). As time progresses rMi approaches rM. 
For all confocal replicates: rM = 1.43 x 10
-7 mol/mL and uM = 1.27 x 10
-6 cm2/s. See Figure I.14 
for comparison of the Equation I.3 model to confocal experimental data.  
!! I.3 CONTINUITY EQUATION DERIVATION  
The one-dimensional pore diffusion equation can be derived by mass balance for the contents 
of a slice of crystal perpendicular to the six-fold crystal axis (v). Here, the axis v points from the 
crystal midline (v = w/2) towards the crystal surface (v = w).  
 Step A. The continuity equation for the mobile guest can be derived from mass balance. The 
accumulation of mobile guest into a z-slice of the crystal, of width Δv and cross-section area, 1, 
(Figure I.7) must be equal to the difference in flux at the two boundaries, in addition to reduction 
in the mobile guest concentration due to adsorption (conversion to the bound state) as well as 
increases in the mobile guest concentration due to desorption (conversion from the bound state). 















∆v + (∆v&)  (Eq. I.5) 
The rate of change for the quantity of mobile guest in the slice is simply the volume of the slice N 
times the rate of change of the concentration of the mobile guest r. The volume of the slice, N, is 









Figure I.7. Diagram of the diffusion axis. 
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along v, the flux across the boundaries of the slice is in accord with Fick’s first law in one 
dimension. 
~89=., = uL o(v) ∙ 1
ÉÑ
ÉÖ ÖÜãÖ
      (Eq. I.6) 
         .<9=., = uL o(v) ∙ 1
ÉÑ
ÉÖ Ö
       (Eq. I.7) 
The change in the local concentration of adsorbed guests with respect to time, Éå
ÉS
, is equal to the 
difference in the rate of adsorption and the rate of desorption. The rate of change for the 
concentration of adsorbed species is the kinetic adsorption coefficient, çU, times the concentration 
of free guest, r v , times the concentration of available binding sites, opUq − o(v) . 
1Ä;|:Å<-|8 = çU ∙ r ∙ opUq − o(v) ∙ 1 ∙ Δv + (Δv
&)    (Eq. I.8) 
u?;|:Å<-|8 = çé ∙ o(v) ∙ 1 ∙ Δv + (Δv
&)        (Eq. I.9) 
Combining Equations I.5, I.6, I.7, I.8, and I.9, and suppressing the z-dependence of o and the q-










− çUr opUq − o 1Δv + çéo1Δv + (Δv
&)  
 (Eq. I.10) 












− çUr opUq − o 1 + çéo1 + (Δv) (Eq. I.11) 
Taking the limit of infinitesimal ∆v, the first term on the right-hand side becomes a derivative, per 







       (Eq. I.12) 
Therefore, as/∆v goes to 0: 








− çUr opUq − o 1 + çéo1    (Eq. I.13) 
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− çUr opUq − o + çéo    (Eq. I.14) 
Here we recover the final continuity equation for the mobile species (CHAPTER 2 Eq. 2.9). 
Step B. The continuity equation for the bound guest can also be derived from mass balance. 
The derivation is similar, but lacking in diffusion terms: 















∆v + (∆v&) (Eq. I.16) 
1Ä;|:Å<-|8 = çU ∙ r ∙ opUq − o(v) ∙ 1 ∙ Δv + (Δv
&)    (Eq. I.17) 
u?;|:Å<-|8 = çé ∙ o(v) ∙ 1 ∙ Δv + (Δv
&)        (Eq. I.18) 




∆v = çUr opUq − o 1Δv − çéo1Δv +  ∆v
&     (Eq. I.19) 
Dividing by 1 ∙ ∆v, and taking the limit as ∆v goes to 0: 
Éå
ÉS
= çUr opUq − o − çéo       (Eq. I.20) 
Here, we recover the Langmuir adsorption kinetic equation (CHAPTER 2 Eq. 2.5). 
!! I.4 PORE DIFFUSION COEFFICIENT 
The nanopores are described using two radii. Whereas KLõ is the radius of the original, 
unobstructed nanopores, KL is the effective radius due to adsorption (the bound species has 






      (Eq. I.21) 
































Figure I.8. Diagram of the initial pore radii (KL›) and the effective pore radii (KL) reduced by 
adsorption of guest Au25(GSH)18. w denotes the length of the pore (i.e. the length of the CJ 










G       (Eq. I.24) 
The volume of an individual spherical guest molecule is taken as £
§
"K§. Multiplying this by 
Avogadro’s number (•X) yields the volume consumed per mole of guest molecules. Multiplying 
this by the local concentration of adsorbed species o(v) [mol / volume] yields a unit-less fraction 
corresponding to the volume fraction consumed by guest. Subtracting the consumed volume 
fraction from Equation S21 yields the free volume fraction. Simplify and rearrange to obtain the 
effective pore radius (CHAPTER 2 Eq. 2.8). 





      (Eq. I.25) 
We can plug this relationship into the empirical function that describes the reduction to the pore 
diffusion when the guest molecule radius (K) is a significant fraction of the effective pore radius 
(KL). 
¶ = K KL         (Eq. I.26) 





    (Eq. I.27) 
uL o v = uM(1 + 1.125¶ ln ¶ − 1.56034¶// + /0.528155¶
&  (Eq. I.28) 
                  +/1.91521¶§ − 2.81903¶£ /+ /0.270788¶2/      
                       +/1.10115¶¨ /− /0.435933¶≠)       
See Figure I.9 for the plot of uL verses KL 
!! I.5 EQUILIBRIUM CONSTANT AND GIBB’S FREE ENERGY 
Regarding CHAPTER 2 Equation 2.4, there are numerous reports discussing the appropriate units 
or lack thereof for the equilibrium constant (Æ) when determining the change in standard Gibb’s 











Figure I.9. Black: the pore diffusion coefficient (uL) as a function of effective pore radius (KL) 
calculated using Equation I.28 with a maximum KL of 6.5 nm (13 nm diameter z-axial pores) and 
a guest molecule radius (K) of 1.54 nm (HYDROPRO1 prediction). Green: highest uL observed at 
early times and at low free-solution concentration (rM). Note: the lowest uL observed occurs at 
late time at high rM (CHAPTER 2 Figure 2.6) when KL approaches K. 
  
! 132!
Æ by multiplying by 55.5 (molarity of water). This approach was also used by Zhou and Zhou6 in 
their assessment of the appropriate units to be used when calculating the thermodynamics of 
adsorption from Langmuir equilibrium constants. The work of Zhou and Zhou reveal the following 
equation to be the most appropriate method for calculating ∆3°from Langmuir constants for liquid-
phase adsorption: 
  ∆3° = −K∞ ln(55.5/Æû±≤)       (Eq. I.29) 
Here, the Langmuir equilibrium constant (Æû) has units of L/g, so multiplication by the molecular 
weight of the adsorbate (±≤) results in units of L/mol. The correction factor 55.5 has units of mol/L 
to obtain a unitless quantity. From the main text equilibrium adsorption experiment we found the 
Langmuir equilibrium constant to be 7.51 L/g. The molecular weight of the Au25(GSH)18 adsorbate 
is 10,456 g/mol. Therefore, the change in standard Gibb’s free energy was calculated to be -37.2 
kJ/mol. 
!! I.6 SIZE CHARACTERIZATION OF GOLD NANOCLUSTERS BY DLS 
Dynamic light scattering (DLS) was performed in triplicate on Au25(GSH)18 nanoclusters 
suspended in 20 mM HEPES pH 8.0 at 20º C using a Malvern Zetasizer Nano ZS with 633nm 
laser. The size distribution by intensity shows two monodisperse peaks with hydrodynamic radii 
of 1.69 ± 0.09 nm and 89.8 ± 12.4 that correspond to monomeric Au25(GSH)18 nanoclusters and 
higher order aggregates respectively (Figure I.10 Left). However, the size distribution by mass 
only reveals the monodisperse 1.69 ± 0.09 nm peak corresponding to monomeric Au25(GSH)18 
nanoclusters (Figure I.10 Right) indicating this is the predominant species in the solution. 
Therefore, KB was set to 1.69 nm in the main text and the free diffusion coefficient uM was 










Figure I.10. Au23(GSH)18 nanocluster size data from DLS analysis. Left: Size distribution by 
intensity shows two monodisperse peaks corresponding to monomeric nanoclusters (1.69 ± 0.09 
nm) and higher order aggregates (89.8 ± 12.4 nm). Right: Size distribution by mass shows only 






only modestly higher than the HYDROPRO1 predicted hydrodynamic radius of 1.54 nm, which 
was retained as the adsorbed guest molecular radius (K). 
!! I.7 HYDROPRO FREE DIFFUSION COEFFICIENT AND GUEST RADIUS 
The free diffusion coefficient (uM) and the radius (K) for Au25(GSH)18 nanoclusters in an 
aqueous environment was determined from the molecular structure (CHAPTER 2 Figure 2.1)7 
using the HYDROPRO hydrodynamic bead model.1 Key HYDROPRO output lines are 
emphasized in Figure I.11. HYDROPRO parameters and results are as follows. Note: the 
experimental hydrodynamic radius (Rh) measured by DLS was somewhat larger. 


















HYDROPRO, Version 10, September 2011 
A. Ortega, D. Amoros, J. Garcia de la Torre, 
"Prediction of hydrodynamic and other solution properties of 
rigid proteins from atomic- and residue-level models" 
Biophys. J. 101, 892-898 (2011). 
------------------------------------------------------------ 
 
SUMMARY OF DATA AND RESULTS 
 
This file : Au25GSH18_20C-res.txt 
Case : 1/10/2017 3:11:10 PM 
Structural file : Au25GSH18.pdb 
 
Radius of elements in primary model : 2.84 Angs. 
Type of hydropro calculation :  1 
Temperature:     20.0 centigrade 
Solvent viscosity:    0.01000 poise 
Molecular weight:     10500. Da 
Solute partial specific volume:  0.520 cm^3/g 
Solution density:     1.000 g/cm^3 
 
Translational diffusion coefficient: 1.394E-06 cm^2/s 
 
Radius of gyration:    1.140E-07 cm 
Volume:      1.197E-20 cm^3 
Rotational diffusion coefficient:  4.515E+07 s^-1 
 
Relaxation time (1):  4.090E-09 s 
Relaxation time (2):  4.083E-09 s 
Relaxation time (3):  4.023E-09 s 
Relaxation time (4):  4.006E-09 s 
Relaxation time (5):  3.986E-09 s 
 
Harmonic mean (correlation) time: 4.037E-09 s 
Intrinsic viscosity:   2.281E+00 cm^3/g 
Sedimentation coefficient: 2.882E+00 Svedberg 
 
Center of diffusion (x):  1.739E-07 cm 
Center of diffusion (x):  1.757E-07 cm 
Center of diffusion (x):  1.755E-07 cm 
 
Generalized (6x6) diffusion matrix:  (Dtt  Dtr) 
                                     (Drt  Drr) 
 
 1.414E-06 -8.063E-09 -1.110E-08    -6.932E-04 -1.592E-03 -1.473E-03 
-7.865E-09  1.417E-06 -6.301E-10    -2.089E-03 -1.152E-02  4.017E-03 
-1.130E-08 -4.394E-10  1.412E-06    -1.679E-03  4.312E-03  1.120E-02 
 
-6.932E-04 -2.089E-03 -1.679E-03     4.517E+07 -1.778E+05 -1.137E+06 
-1.592E-03 -1.152E-02  4.312E-03    -1.765E+05  4.533E+07  3.111E+05 
-1.473E-03  4.017E-03  1.120E-02    -1.136E+06  3.135E+05  4.494E+07 
 
List of equivalent radii 
Translational: 1.540E-07 
Gyration :  1.472E-07 
Volume :  1.419E-07 
Rotation (1):  1.581E-07 
Rotation (2):  1.580E-07 
Rotation (3):  1.572E-07 
Rotation (4):  1.570E-07 
Rotation (5):  1.567E-07 
Rotation (h):  1.552E-07 
 
Intrinsic viscosity:   1.560E-07 
Longest distance:   1.810E-07 
Longest distance :   3.619E-07 cm 
 
Figure I.11. HYDROPRO output for determining the hydrodynamic parameters of Au25(GSH)18. 




Table I.1. Equilibrium adsorption isotherm fit quality. Data were fit to their respective isotherm 
equations via least squares using the Matlab version 9.1.0 Curve Fitting Tool (Natick, MA). 
Equations were adopted from work done by Xunjun Chen on modeling experimental adsorption 
isotherm data.8 SSE refers to the sum of squared errors. R2 refers to the coefficient of multiple 
determination. DFE refers to the residual degrees of freedom (the number of response values minus 
the number of fit coefficients). AdjrSqr refers to a degree of freedom adjusted R2 value. RMSE 
refers to the root mean squared error.  
 
 SSE R2 DFE AdjrSqr RMSE Equation 
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Figure I.12. Comparison of Langmuir (left) and Freundlich (right) non-linear (top) and linear 
(bottom) equilibrium adsorption isotherms. The fit was slightly superior for the Langmuir isotherm 




Figure I.13. Absorption standard used to determine the concentration of Au25(GSH)18 nanoclusters 




Figure I.14. Effective concentration (rMi) at the crystal surface boundary as a function of time; 
Replicate data values (R1, R2, and R3) represent the average free-solution concentration at the 
crystal boundary obtained from confocal images while model values were calculated using 






Figure I.15. Individual fits to three replicate 60-minute confocal loading experiments. Fit results 
can be found in Table 2 of the main text. (A.) Concentration, distance, and time surface plots of 
the left-hand side (v @ ) to v @ wxy) of replicate diffusion profiles. Left: confocal data. Right: 
FEM fit data. (B.) Comparison of replicate FEM fits to the respective experimental confocal data, 
the fit line represents the sum of r and o.  Left: data taken just inside the crystal at the boundary 
(v @ )) over the entire 60-minutes. Right: data taken at the 60-minute time point over the entire 
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CHARACTERIZING THE CYTOCOMPATIBILITY OF VARIOUS CROSS-LINKING 





!! II.1 REAGENTS 
 
The following chemicals were purchased and used without further purification. From Sigma-
Aldrich: dimethylamine borane complex (DMAB), trimethylamine N-oxide (TMAO), 
glutaraldehyde solution (GA) (25% in H2O), 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC), sodium phosphate dibasic (Na2HPO4), potassium phosphate monobasic (KH2PO4), 
ammonium sulfate ([NH4]2SO4), and sodium acetate (CH3COONa). From VWR: HEPES, 
glycerol, and bis-tris. From Acros Organics: glyoxal solution (40% in H2O) referred to as 
oxaldehyde (OA) throughout this manuscript. From Alfa Aesar: hydroxylamine solution (50% in 
H2O) and imidazole. From EMD Millipore: sulfuric acid (H2SO4). From PHARMCO-AAPER: 
Ethyl Alcohol 200 proof. From Fisher Scientific: sodium borate, boric acid, NaCl and KCl. From 
J.T. Baker: citric acid.  
Other reagents from Thermo Scientific and Sigma-Aldrich were used to make mTacsimateTM: 
1.83 M malonic acid, 0.25 M sodium citrate, 0.12 M succinic acid, 0.3 M D-L malic acid, 0.4 M 
acetic acid, 0.5 M sodium formate, and 0.16 M sodium tartrate—titrated to pH 7.5. mTacsimateTM 
is a modified blend of TacsimateTM from Hampton Research that removes ammonium from the 





!! II.2 PROTEIN EXPRESSION, PURIFICATION, AND CRYSTALLIZATION 
t!Lyophilized hen egg white lysozyme (HEWL) was purchased from Hampton Research (Cat. 
#: 12650-88-3), used with no further purification, and crystallized per a modified version of a 
previously reported bulk crystallization method.1 Three stock solutions were made: 160 g/L 
NaCl in DI water, 85 g/L HEWL in DI water, and 100 mM sodium acetate pH 4.6 in DI water. 
HEWL stock solution was stored at 10 °C or lower when not in use. The three stock solutions 
were added to a single well of a 9 cavity PYREX spot plate in consecutive order: 50 µL sodium 
acetate solution, 50 µL NaCl solution, and 100 µL HEWL stock solution. The solution mixture 
was gently pipetted to mix and allowed to incubate without disturbance at room temperature 
for 24 hours. After 24 hours, lysozyme crystals have grown and are visible in solution and on 
the surface of the glass plate; longer growth times yielded larger crystals. 
The target gene CJ was modified from the gene vector encoding protein CJ0 obtained from 
the Protein Structure Initiative: Biology-Materials Repository (Genebank ID: cj0420, Protein 
Data Bank ID: 2fgs). For ease of uniform expression and purification, the CJ0 gene was codon 
optimized and the periplasmic signaling peptide deleted thereby yielding CJ. The CJ gene was 
encoded in expression vector pSB3 with a C-terminal 6xHis tag and expressed in Escherichia 
coli BL21(DE3) pLysS cells using a glucose/lactose induction system2 at 17° C for 36 hours.  
Cells were lysed by sonication and the CJ protein purified via nickel affinity capture on a 
HisTrap HPTM column (GE Healthcare). A single chromatography step provided sufficient 
purity for crystallization. Purified CJ protein was buffer exchanged into 0.15 M NaCl, 10 mM 
HEPES, and 10% glycerol at pH 7.5, concentrated to 15 mg/mL, and stored at -30° C. CJ-
LPCs were grown overnight by sitting drop vapor diffusion at 20° C in 3.3–3.6 M AmSO4, 100 
mM bis-tris at pH 7.0. 
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!! II.5 CJ-LPC MATERIAL CROSS-LINKING 
In all cases, cross-linking was performed under conditions as similar as possible to the crystal 
growth conditions to mitigate crystal degradation caused by harsh solution conditions. 
"! II.5.1 Glutaraldehyde (GA) 
Prior to cross-linking, crystals were washed by loop transferring them into a 90% 
mTacsimateTM, 10% glycerol mixture at pH 7.5 for 1 hour to remove residual CJ monomers. 
Crystals were then transferred into a fresh mixture of 90% mTacsimateTM, 10% glycerol at pH 7.5, 
and cross-linked for 2 hours by the direct addition of 1% glutaraldehyde and 25 mM DMAB. The 
cross-linking reaction was quenched by transferring CJ-LPCs into a solution of 0.3 M 
hydroxylamine, 25 mM DMAB, 0.15 M NaCl, and 0.1 M citric acid at pH 5.0 for 1 hour. After 
cross-linking and quenching, the crystals were washed and stored in fresh 4.2 M TMAO, 175 mM 
H2SO4 solution at pH 7.5. 
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"! II.5.2 Oxaldehyde (OA) 
Prior to cross-linking, crystals were washed by loop transferring them into a 90% 
mTacsimateTM, 10% glycerol mixture at pH 7.5 for 1 hour to remove residual CJ monomers. 
Crystals were then transferred into a fresh mixture of 90% mTacsimateTM, 10% glycerol at pH 7.5, 
and cross-linked for 2 hours by the direct addition of 1% OA and 25 mM DMAB. The cross-
linking reaction was quenched by transferring CJ-LPCs into a solution of 0.3 M hydroxylamine, 
25 mM DMAB, 0.15 M NaCl, and 0.1 M citric acid at pH 5.0 for 1 hour. After cross-linking and 
quenching, the crystals were washed and stored in fresh 4.2 M TMAO, 175 mM H2SO4 solution 
at pH 7.5. 
"! II.5.3 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) 
Prior to cross-linking, crystals were washed by loop transferring them into a 4.2 M TMAO, 
175 mM H2SO4 solution at pH 7.5 for 1 hour to remove residual CJ monomers. After washing, 
crystals were transferred into a fresh mixture of 4.2 M TMAO, 175 mM H2SO4 at pH 7.5 
containing 100 mM EDC, 50 mM imidazole and cross-linked for 1 hour. Crystals were then moved 
to a second cross-linking mixture of 5.0 M NaCl, 200 mM MES pH 5.5 containing 200 mM EDC, 
100 mM imidazole, 50 mM sodium malonate and cross-linked for an additional 2 hours. The cross-
linking reaction was quenched by transferring CJ-LPCs into 5.0 M NaCl, 100 mM Borate buffer 
pH 10.0 for 30 min. After cross-linking and quenching, the crystals were washed and stored in 
fresh 4.2 M TMAO, 175 mM H2SO4 solution at pH 7.5. 
!! II.6 HEWL MATERIAL CROSS-LINKING 
In all cases, cross-linking was performed under conditions as similar as possible to the crystal 
growth conditions to mitigate crystal degradation caused by harsh solution conditions.  
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"! II.6.1 Glutaraldehyde (GA) 
Prior to cross-linking, crystals were washed by loop transferring them into 2.5 M NaCl, 50 mM 
sodium acetate pH 4.6 for 15 minutes to remove residual HEWL monomers. Crystals were then 
transferred into a fresh mixture of 2.5 M NaCl, 50 mM sodium acetate pH 4.6 containing 10% 
glutaraldehyde and cross-linked for 2 hours. The cross-linking reaction was quenched by 
transferring HEWL crystals into a solution of 0.3 M hydroxylamine, 25 mM DMAB, 0.15 M NaCl, 
and 0.1 M citric acid at pH 5.0 for 1 hour. After cross-linking and quenching, the crystals were 
washed and stored in fresh 2.5 M NaCl, 50 mM sodium acetate pH 4.6. 
"! II.6.2 Oxaldehyde (OA) 
Prior to cross-linking, crystals were washed by loop transferring them into 2.5 M NaCl, 50 mM 
sodium acetate pH 4.6 for 15 minutes to remove residual HEWL monomers. Crystals were then 
transferred into a fresh mixture of 2.5 M NaCl, 50 mM sodium acetate pH 4.6 containing 10% 
oxaldehyde and cross-linked for 2 hours. The cross-linking reaction was quenched by transferring 
HEWL crystals into a solution of 0.3 M hydroxylamine, 25 mM DMAB, 0.15 M NaCl, and 0.1 M 
citric acid at pH 5.0 for 1 hour. After cross-linking and quenching, the crystals were washed and 
stored in fresh 2.5 M NaCl, 50 mM sodium acetate pH 4.6. 
"! II.6.3 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) 
Prior to cross-linking, crystals were washed by loop transferring them into 2.5 M NaCl, 50 mM 
MES buffer at pH 5.5 for 15 minutes to remove residual HEWL monomers. After washing, crystals 
were transferred into a fresh mixture of 2.5 M NaCl, 50 mM MES buffer at pH 5.5 containing 100 
mM EDC, 50 mM imidazole, and cross-linked for 1 hour. Crystals were then moved to a second 
cross-linking mixture of 2.5 M NaCl, 200 mM MES buffer at pH 5.5 containing 200 mM EDC, 10 
mM imidazole, 50 mM sodium malonate and cross-linked for an additional 2 hours.  The cross-
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linking reaction was quenched by transferring HEWL crystals into 2.5 M NaCl, 100 mM Borate 
buffer pH 10.0 for 30 min. After cross-linking and quenching, the crystals were washed and stored 
in fresh 2.5 M NaCl, 50 mM sodium acetate pH 4.6. 
!! II.7 EXPERIMENTAL PROTOCOLS 
"! II.7.1 Stereomicroscopy Imaging 
To monitor potential changes in the macroscopic crystal morphology and surface structure, all 
cross-linked CJ-LPCs and HEWL crystals were imaged using a Motic SMZ168 Series Stereo 
Zoom Microscope immediately following cross-linking (CHAPTER 3 Figure 3.2 pre-incubation) 
and again after a 24-hour incubation with HDFa cells (CHAPTER 3 Figure 3.2 post-incubation) 
at 37° C with 5% CO2 
No macroscopic degradation of crystal structure or changes in morphology were observed in 
any of the cross-linked CJ-LPC samples (CJ/GA, CJ/OA, and CJ/EDC) immediately following 
cross-linking when compared to washed non-cross-linked (NCL) CJ-LPCs. In addition, none of 
the cross-linked CJ-LPC samples demonstrated substantial macroscopic degradation of crystal 
structure or changes in morphology after incubation with HDFa cells. However, CJ/NCL samples 
completely dissolved after incubation with HDFa cells. This data indicates that all three cross-
linking chemistries are necessary and sufficient to stabilize the macroscopic crystal morphology 
and surface structure of CJ-LPCs.  
In contrast, after initial cross-linking of HEWL crystals, substantial cracks were observed in 
the EDC cross-linked crystals (HEWL/EDC) and slight cracking in the OA cross-linked crystals 
(HEWL/OA). After incubation with HDF cells HEWL/NCL and HEWL/EDC crystals completely 
dissolved while HEWL/OA crystals demonstrated severe cracking and disintegration. No 
substantial macroscopic degradation of crystal structure or substantial changes in morphology 
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were observed in HEWL crystals cross-linked with GA. This data indicates that only GA is 
sufficient to stabilize the macroscopic crystal morphology and surface structure of HEWL crystals. 
"! II.7.2 Scanning Electron Imaging 
The size distribution of fragmented crystals was determined using a JEOL JSM-6500F field 
emission scanning electron microscope equipped with a Thermo Electron energy dispersive X-ray 
spectrometer (EDS). Multiple SEM images were stitched together using Fiji3,4 to form a large 
tagged image file (Figure II.1A) of a desiccated 1-2 µL drop of fragmented CJ-LPC material 
suspended in pure H2O. A binary image (Figure II.1B) was then created and processed using 
particle analysis in Fiji to generate particle size data which was quantified via histogram plotting 
tools in MATLAB version 9.1.0 (Natick, MA) (Figure II.1C). 
"! II.7.3 CJ Crystal X-ray Diffraction (XRD) and Data Processing 
All CJ-LPC materials were loop transferred into cryoprotectant (4.2 M TMAO, 175 mM H2SO4 
pH 7.5) and soaked for at least 5 minutes prior to flash freezing in a cryogenic nitrogen stream at 
100 K. The diffraction quality was then assessed using a Rigaku Compact HomeLab with a micro-
focus X-ray generator and a Pilatus 200K detector based on a 15-frame data collection strategy; 
each frame was separated by a 2.0° omega offset and exposed for 60 seconds. Reflection data was 
indexed and scaled using HKL-3000 software (HKL Research Inc.). See Tables II.1-II.5 for scale 
output logs for CJ-LPC. The high-resolution estimates for all CJ-LPCs was based on a signal to 
noise ratio above two (Ave. I / Ave. Err  ≥ 2.0). Refer to CHAPTER 3 Figure 3.3 for representative 









Figure II.1. (A) SEM image mosaic composed of 41 images showing fragmented CJ-LPCs. Panel: close-up of particles. Scale Bar: 50 
!m. (B) Binary image of (A), used for particle analysis. (C) Histogram of particle spherical radii calculated from total particle area. 













Table II.1. X-ray diffraction scale output logs for non-cross-linked CJ-LPCs prior to incubation 
















Table II.2. X-ray diffraction scale output logs for EDC cross-linked CJ-LPCs prior to incubation 
















Table II.3. X-ray diffraction scale output logs for EDC cross-linked CJ-LPCs after incubation 
















Table II.4. X-ray diffraction scale output logs for OA cross-linked CJ-LPCs prior to incubation 
















Table II.5. X-ray diffraction scale output logs for OA cross-linked CJ-LPCs after incubation with 





!! II.7.4 HEWL Crystal X-ray Diffraction (XRD) and Data Processing 
All HEWL materials were loop transferred into 2.5 M NaCl, 50 mM sodium acetate pH 4.6 
and soaked for at least 5 minutes prior to flash freezing in a cryogenic nitrogen stream at 100 K. 
The diffraction quality was then assessed using a Rigaku Compact HomeLab with a micro-focus 
X-ray generator and a Pilatus 200K detector based on a 15-frame data collection strategy; each 
frame was separated by a 2.0° omega offset and exposed for 60 seconds. Reflection data was 
indexed and scaled using HKL-3000 software (HKL Research Inc.). See Tables II.6-II.8 for scale 
output logs for HEWL data and Tables II.1-II.5 for CJ-LPC data. The high-resolution estimates 
for all HEWL crystals was based on a signal to noise ratio above two (Ave. I / Ave. Err  ≥ 2.0). 
Refer to CHAPTER 3 Figure 3.3 for representative diffraction patterns and a summary of the high-
resolution estimates for each HEWL material type. 
!! II.7.5 Adult Human Dermal Fibroblast (HDFa) Cell Culture 
Adult human dermal fibroblast cells were purchased from Thermo Fisher (Cat. #: C0135C) 
and cultured in freshly supplemented medium 106 (Thermo Fisher Cat #: M106500) at 37° C with 
5% CO2. 
!! II.7.6 Human Macrophage (MV-4-11) Cell Culture 
Human macrophage cells were purchased from ATCC (Cat. #: CRL-9591) and cultured in 
freshly supplemented Iscove's Modified Dulbecco's Medium (IMDM) from ATCC (Cat. #: 30-
2005) at 37° C with 5% CO2. 
!! II.7.7 HDFa Incubation Stability Tests 
HDFa cells (passage number: 4) were plated at 15,000 cells per well (150,000 cells/mL) in a 
96-well plate and allowed to adhere for 24 hours at 37° C with 5% CO2. After the initial 24-hour 













Table II.6. X-ray diffraction scale output logs for non-cross-linked HEWL crystals prior to 
















Table II.7. X-ray diffraction scale output logs for EDC cross-linked HEWL crystals prior to 
















Table II.8. X-ray diffraction scale output logs for EDC cross-linked HEWL crystals after 





allowed to incubate for 24 hours at 37° C with 5% CO2 to test the stability of the crystals under 
cell culture conditions. After 24 hours, the crystal morphology and surface structure was analyzed 
via stereomicroscopy (CHAPTER 3 Figure 3.2) and the molecular order of the crystals was 
analyzed using XRD on a Rigaku HomeLab (Tables II.1-II.8 and CHAPTER 3 Figure 3.3). 
!! II.7.8 Crystal Fragmentation by Sonication 
Evidence has been found that increasing the surface area of potentially toxic mesoporous solids 
may lead to increases in the cytotoxic response in vitro.5 Therefore, to maximize the potential of 
observing a cytotoxic response in the LDH assay, we used high surface area fragmented CJ-LPC 
and HEWL protein crystals. Large quantities of small (5.8 ± 3.9 µm) fragmented crystals were 
generated by sonicating hundreds of large (100-500 µm) non-cross-linked protein crystals (Figure 
II.1). Large protein crystals were first washed by loop transferring them into their respective wash 
conditions to remove residual monomers: CJ-LPCs were washed for 1 hour in 90% mTacsimateTM, 
10% glycerol mixture at pH 7.5 for aldehyde cross-linking and 4.2 M TMAO, 175 mM H2SO4 
solution at pH 7.5 for EDC cross-linking, HEWL crystals were washed for 15 minutes in 2.5 M 
NaCl, 50 mM sodium acetate pH 4.6. After washing all crystals were then loop transferred into 
fresh wash solutions and slowly sonicated on ice. Fragmented crystals were then cross-linked per 
the same cross-linking protocol as their large CJ-LPC and HEWL crystal counterparts (see sections 
II.5 and II.6). Note that in the case of fragmented protein crystals, the fragments were too small to 
loop transfer, thus dialysis was used as an alternative means to transfer the crystals into new 
solution conditions. After cross-linking and quenching all reactions, the fragmented crystals were 
sterilized by dialysis into their respective wash conditions containing 20% EtOH followed by 
dialysis transfer into sterile 1x PBS and either sterile supplemented cell culture media (HDFa cells) 
or double deionized water (MV-4-11 cells). 
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!! II.7.9 Live/Dead Staining 
To validate the LDH cytotoxicity results, cells from the control well (no materials added) and 
cells from wells containing 400 µg/mL of cross-linked protein crystal material were taken and 
stained using the Live/Dead Viability Kit for Mammalian Cells from Thermo Scientific (Cat. #: 
L3224). Calcein was used to reveal living cells and ethidium homodimer to reveal dead cells. 
Fluorescent images of the control cells as well as the cells incubated with CJ/OA and CJ/EDC 
materials were taken on an Olympus IX73 fluorescent light microscope while the cells incubated 
in both GA cross-linked materials (CJ/GA and HEWL/GA) were taken on a Nikon DIAPHOT 300 
light microscope with MetaMorph version 7.7 software. All images were taken using the 470 nm 
and 595 nm excitation lasers to excite live (green) and dead (red) cells respectively. Results 
indicate no substantial differences between the control cells and the CJ/EDC or CJ/OA cells 
(CHAPTER 3 Figure 3.4C-3.4E) while both CJ/GA and HEWL/GA cells show approximately 
50% cell death (CHAPTER 3 Figure 3.4F & 3.4G). These results agree with the quantitative LDH 
cell viability results (CHAPTER 3 Figure 3.4A & 3.4B). 
!! II.7.10 Lactate Dehydrogenase (LDH) cytotoxicity Assay 
The short-term cytotoxic response of human cells to various cross-linked protein crystal 
materials was quantified by measuring the LDH activity in the cell culture medium of HDFa and 
MV-4-11 human cell lines. HDFa cells (passage number: 3) were plated at 150,000 cells/mL 
(15,000 cells per well) in a 96-well plate and allowed to adhere for 24 hours at 37° C with 5% 
CO2. After the initial 24-hour incubation, the culture medium was aspirated and replaced with 
fresh medium (negative control) or medium containing various concentrations (1, 50, 100, 200, 
and 400 µg/mL) of fragmented protein crystal material: non-cross-linked (CJ/NCL & 
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HEWL/NCL), GA cross-linked (CJ/GA & HEWL/GA), OA cross-linked (CJ/OA), or EDC cross-
linked (CJ/EDC). The cells were then incubated for an additional 24 hours at 37° C with 5% CO2.  
The LDH assay had to be adjusted slightly for MV-4-11 cells due to the fact that they are a 
suspended culture. First, either sterile double distilled water (negative control) or sterile double 
distilled water containing 400 µg/mL of fragmented protein crystal material: non-cross-linked 
(CJ/NCL & HEWL/NCL), GA cross-linked (CJ/GA & HEWL/GA), OA cross-linked (CJ/OA), or 
EDC cross-linked (CJ/EDC) were added to a 96-well culture plate and allowed to desiccate for 24 
hours in a laminar flow hood. After the initial 24-hour desiccation period, MV-4-11 cells (passage 
number: 3) were added to each well at a concentration of 150,000 cells /mL and incubated for 24 
hours at 37° C with 5% CO2. 
After 24-hours of incubation with the materials the cell culture medium was removed from 
each sample well and the LDH activity measured using the Pierce LDH Cytotoxicity Assay Kit 
from Thermo Scientific (Cat. #: 88953). Percent cell viability was calculated using the following 
equation: 
%"#$%%"&'()'%'*+ = 100 −" 01"2345647"89:";<6=>=6?"–"ABCD65D4CEF"89:";<6=>=6?
G5H=IEI"89:";<6=>=6?"–"ABCD65D4CEF"89:";<6=>=6?
×100   
 (Eq. II.1) 
Where the Spontaneous LDH Activity refers to the cell samples with no material present while the 
Maximum LDH Activity refers to complete cell death triggered by the addition of 10 µL of lysis 
buffer. Results can be found in CHAPTER 3 Figure 3.4A. 
!! II.7.11 Nitrite Detection Assay 
The potential for human macrophage activation caused by short-term contact with various 
protein crystal materials was investigated by quantifying the total nitrite/nitrate concentration in 
the media of MV-4-11 cells using the Nitric Oxide Colorimetric Assay from Roche (Cat. #: 
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11756281001). The cell culture for this assay was set up the same as that of the LDH cytotoxicity 
assay. Cells were incubated for 24-hours at 37° C with 5% CO2 in the presence of 400 µg/mL 
fragmented protein crystal material. Media was taken from each well and all nitrate in the solution 
was converted to nitrite by the enzyme nitrate reductase in the presence of NADPH. Results show 
that MV-4-11 cells incubated with each of the various protein crystal materials produced similar 
nitrite levels as MV-4-11 cells that were incubated in the absence of material (cells only) 
(CHAPTER 3 Figure 3.5B). This indicates that none of the protein crystal materials alone could 
activate the release of nitric oxide from MV-4-11 human macrophages. 
!! II.7.12 Endotoxin Assay 
Endotoxins are produced by certain gram-negative bacterium such as Escherichia coli (E. coli). 
Considering that CJ proteins used in this study were expressed in E. coli, it was necessary to 
measure the endotoxin levels present in the various steps of CJ-LPC material preparation. This 
was done using the Pierce LAL Chromogenic Endotoxin Quantitation Kit from Thermo Scientific 
(Cat. #: 88282). See Figure II.2 for the endotoxin standard. Each step of the material preparation 
(protein purification, crystallization, and cross-linking) helps to remove residual endotoxins as 
seen in Figure II.3.   
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Figure II.2. Endotoxin standard.  
 
Figure II.3. Endotoxin levels at various stages of CJ-LPC material preparation. Endotoxin 
concentration is presented using endotoxin units (EU) per milliliter. Error Bars: standard 
deviation, n=3. Note that fragmented CJ-LPCs (fCJ-LPCs) were used for the non-cross-linked 
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TEXTILE FUNCTIONALIZATION BY POROUS PROTEIN CRYSTAL CONJUGATION 




"! III.1 REAGENTS 
 
The following chemicals were purchased and used without further purification. From Sigma-
Aldrich: acetone, 1,1’-carbonyldiimidazole (CDI), dimethylamine borane complex (DMAB), 
trimethylamine N-oxide (TMAO), glutaraldehyde solution (GA) (25% in H2O), sodium phosphate 
dibasic (Na2HPO4), sodium hypophosphite monohydrate, potassium phosphate monobasic 
(KH2PO4), and ammonium sulfate ([NH4]2SO4). From VWR: HEPES and bis-tris. From Acros 
Organics: glyoxal (oxaldehyde) solution (40% in H2O), carbohydrazide. From EMD Millipore: 
sulfuric acid (H2SO4), and sodium acetate. From Tokyo Chemical Industry Co.: adipic acid 
dihydrazide (AAD). From Fisher Scientific: sodium borate, NHS-fluorescein, sulforhodamine 101 
(non-reactive), NaCl, and KCl. From J.T. Baker: citric acid. From Chemodex: sulforhodamine 101 
acid chloride (TexasRed). From Hampton Research: lyophilized hen egg white lysozyme (HEWL).  
"! III.2 CJ VARIANT EXPRESSION AND PURIFICATION 
 
The target gene CJ was modified from the gene vector encoding protein CJ0 obtained from the 
Protein Structure Initiative: Biology-Materials Repository (Genebank ID: cj0420, PDB Code: 
2FGS). For ease of uniform expression and purification, the CJ0 gene was codon optimized and 
the periplasmic signaling peptide deleted thereby yielding CJ. The CJ gene was encoded in 
expression vector pSB3 with a C-terminal 6xHis tag and expressed in Escherichia coli C41-DE3 
cells. 1 mL of turbid starter culture was added to 500 mL Terrific Broth (TB) with 100 mg/mL 
kanamycin and incubated at 37º C with shaking at 250 rpm until lightly turbid (~2.5-3 hours). 
Protein expression was induced with 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) 
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followed by overnight (~16 hour) incubation at 25º C with shaking at 250 rpm. Cells were lysed 
by sonication and the CJ protein purified via gravity Ni-NTA affinity capture followed by 
ammonium sulfate ([NH4]2SO4) precipitation. Purified CJ protein was buffer exchanged into 0.5 
M [NH4]2SO4, 10 mM HEPES, and 10% glycerol at pH 7.4, concentrated to ~40 mg/mL, and 
stored at -30° C. 















"! III.3 CRYSTALLIZATION 
!! III.3.2 HEWL Batch Crystallization 
Three stock solutions were made: 160 g/L NaCl in DI water, 85 g/L HEWL in DI water, and 
100 mM sodium acetate pH 4.6 in DI water. HEWL stock solution was stored at 10 °C or lower 
when not in use. The three stock solutions were added to a single well of a 9 cavity PYREX spot 
plate in consecutive order: 50 µL sodium acetate solution, 50 µL NaCl solution, and 100 µL HEWL 
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stock solution. The solution mixture was gently pipetted to mix and allowed to incubate without 
disturbance at room temperature for 24 hours. After 24 hours, visible lysozyme crystals could be 
seen in solution and on the surface of the glass plate; longer growth times yielded larger crystals.  
!! III.3.2 CJ Batch Crystallization 
Approximately 40 mg/mL CJ was mixed with 3.4 M [NH4]2SO4, 40 mM bis-tris pH 6.5 in a 
PYREX spot plate well at a protein to precipitant ratio of 2.7:1 at a total volume of 185 µL. Plates 
were incubated at 15 . After 24 hours, CJ-LPCs have grown and are visible in solution.  
"! III.4 CROSS-LINKING AND TRACE-LABELING 
!! III.4.1 HEWL Crystals 
After crystallization, HEWL crystals adhere to the well surface of the PYREX spot plate. 
Mother liquor was removed from the crystallization well by pipette (being careful not to disturb 
the immobilized crystals) and replaced with 56 g/L NaCl, 50 mM sodium acetate pH 4.6 for 30 
minutes to remove excess HEWL monomers. The crystallization well solution was replaced with 
fresh 56 g/L NaCl, 50 mM sodium acetate pH 4.6 and crystals were crosslinked for 30 minutes at 
room temperature by direct addition of glutaraldehyde yielding a 5% (v/v) concentration in the 
crystallization well. Cross-linking reaction quench and crystal trace-labeling were achieved by 
replacing crystallization well solution with 0.25 M carbohydrazide, 0.25 mM NHS-fluorescein, 
100 mM DMAB in 1x PBS pH 7.5. HEWL crystals were removed from the surface of the PYREX 
spot plate by gentle scraping and stored in fresh 4.2 M TMAO, 0.175 M H2SO4 at pH 7.5. 
!! III.4.2 CJ-LPCs 
After crystallization, CJ-LPCs do not adhere to the surface of the PYREX spot plate wells. 
Thus, all crystals and mother liquor in the crystallization well were transferred to a microcentrifuge 
tube by pipette. CJ-LPCs remaining in the well after the initial transfer were transferred by rinsing 
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out with 4.2 M TMAO, 0.175 M H2SO4 pH 7.5. Crystals in solution were centrifuged on a bench 
top centrifuge for 2 minutes. The supernatant was then replaced with fresh 4.2 M TMAO, 0.175 
M H2SO4 pH 7.5. This process was repeated twice at 10-minute intervals. Light agitation was used 
to break up crystal pellet after the final sedimentation. Crystals were then crosslinked for 3 minutes 
at room temperature by direct addition of glutaraldehyde or oxaldehyde at 5% (v/v) final 
concentration. The cross-linking reaction was quenched and crystals trace-labeled by replacing the 
cross-linking solution with 0.25 M carbohydrazide, 0.25 mM NHS-fluorescein, 100 mM DMAB 
in 1x PBS pH 7.5.  
"! III.5 FABRIC ATTACHMENT CHEMISTRY 
!! III.5.1 Citric Acid Textile Treatment 
1” x 1” cotton fabric test swatches were placed in 2% (w/v) sodium borate solution for 1 hour 
at 90  and subsequently rinsed with 1x PBS pH 7.5 at room temperature. Groups of 6 fabric 
swatches were placed in 50 mL centrifuge tubes containing 25 mL 7% citric acid, 5% sodium 
hypophosphite and vortexed for 1 hour. Swatches were dab-dried with Kimwipes® and incubated 
on aluminum foil (shiny side facing swatches) in an oven at 85° C and 160° C for 5 minutes at 
each temperature. Citric-acid-treated intermediate fabric swatches were used for further 
chemistries within 24 hours. 
!! III.5.2 CDI Textile Treatment 
Citric acid intermediate swatches were washed twice with new, pure acetone. Before swatches 
dried, 0.25 g/mL CDI in acetone was pipetted directly onto 5 evenly distributed treatment locations 
(~12 mm diameter) on each fabric swatch and immediately sealed in an incubation apparatus with 









Figure III.1. CDI treatment incubation in “sandwich” apparatus: (A) 24-well sitting drop 
crystallization plate. (B) Kimwipes® saturated with acetone to prevent drying. (C) Fabric swatches 
activated with CDI at 5 evenly distributed locations. (D) Stainless steel plate to provide weight 
and prevent corrosion of plastic crystallization plate. (E) Crystallization plate cover.   
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twice with acetone after incubation. CDI-treated intermediate swatches were used for further 
chemistries within 24 hours. 
!! III.5.3 AAD Textile Treatment 
CDI-intermediate fabric swatches were vortexed in 1 M AAD, 20 mM HEPES pH 8.0 for 3 
hours at room temperature and subsequently rinsed with 20 mM HEPES pH 8.0. AAD-treated 
intermediate swatches were used for further chemistries within 24 hours. 
!! III.5.4 Crystal Attachment to CDI-Intermediate Fabric  
40 µL of crosslinked protein crystals (either variant) in 20 mM HEPES pH 8.0 were pipetted 
onto treatment locations of CDI-intermediate fabric swatches and allowed to incubate overnight at 
room temperature in an airtight container. 
!! III.5.5 Crystal Attachment to AAD-Intermediate Fabric 
Protein crystals (either variant) were transferred to 20 mM HEPES pH 8.0. Glutaraldehyde (or 
oxaldehyde) was added to the crystal mixture to achieve a 2.5% (v/v) concentration in solution. 
After gentle mixing, the cross-linker and protein crystal solution was pipetted onto the treatment 
locations of AAD-intermediate fabric swatches, placed in a sealed “sandwich” apparatus (as seen 
in Figure III.1), and allowed to incubate at room temperature overnight.  
"! III.6 CRYSTAL RETENTION TESTING AND IMAGING  
The Crystal attachment retention was tested using a modified version of the colorfastness 
laundering protocol AATC Test Method 61-2013 1A.1 Test Method 1A (45-minute duration) is 
meant to simulate the color change due to 5 careful hand-washes. Each fabric swatch containing 
conjugated crystals was subjected to a 15-minunte accelerated laundering machine pre-wash in a 
steel lever-lock canister containing 200 mL DI H2O and 10 steel beads to remove excess non-
covalently attached crystals from the fabric surface. Swatches were then washed for a total of 60 
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minutes (15 minute increments) at 40 ± 2º C in steel-lever canisters containing 200 mL DI H2O, 
0.74 g powder detergent, and 10 steel beads. 
Crystal retention was quantified before and after each 15-minute wash increment (including 
pre-wash) by imaging on a Typhoon FLA 7000 fluorescent scanner at 473 nm and 10 µm 
resolution. Images were analyzed using the Fiji software package2 to detect and count points of 
fluorescent intensity corresponding to retained trace-labeled crystals (Figure III.2). Raw and 
normalized retention data is shown in Tables III.1—III.4.  
 Control samples were prepared in which either the cotton fabric was not activated with citric 
acid (CA) to add carbocyclic acid groups to the surface of the cotton (-CA), or they did not receive 
CDI treatment (-CDI sample). Control swatches were imaged both before and after the DI H2O 
rinse (Figure III.3A & III.3B). These images reveal substantial loss of protein crystal material in 
both control samples with near zero crystal retention. These results indicate CA activation and CDI 
treatment are critical in completing the CDI-only conjugation reaction. Similarly, CA activated 
fabric treated with GA (instead of CDI) showed near-zero crystal retention (Figure III.3C), 
indicating that the improved retention seen in the CDI+AAD+GA conjugation scheme is not 
simply due to the addition of GA alone. 
"! III.7 CRYSTAL GUEST LOADING 
To remove weakly adsorbed crystals, all fabric samples used for loading were subject to a 10-
minute hand-shaken pre-wash in a steel lever-lock canister containing 200 mL DI H2O and 10 steel 
beads. Fluorescence and DIC imaging was done using a Nikon Eclipse Ti spinning-disk confocal 











Figure III.2. (A) Representative Typhoon image showing fluorescently labeled crystals. (B) 
Detection and quantification of crystal puncta using Fiji software.  
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Table III.3. CJ-LPC retention using CDI+AAD+OA conjugation. 
 
 












Figure III.3. Control samples for protein crystal conjugation to cotton fabric. Left: pre H2O rinse; 
Right: post DI H2O rinse, note: samples were not subjected to any laundering time. GA cross-
linked, quenched, and NHS-fluorescein trace-labeled HEWL crystals were used in all samples.  
(A) Cotton not activated with citric acid. (B) Cotton not treated (conjugated) with CDI. (C) Cotton 
activated with citric acid and treated (conjugated) with GA.  
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!! III.7.1 Sulforhodamine 101 Loading into HEWL Crystals 
Rinsed fabric samples containing conjugated HEWL crystals labeled with NHS-fluorescein 
were placed in 50 mM HEPES, 150 mM NaCl, 10% Glycerol pH 7.5 and imaged under brightfield 
light (DIC), 488 nm laser light (HEWL fluorescein) and 561 nm laser light (to test for crystal, see 
CHAPTER 4 Figure 4.4A Left. Next, the fabric samples were added to 500 µL sulforhodamine 
101 in 50 mM HEPES, 150 mM NaCl, 10% Glycerol pH 7.5 and incubated for 24 hours in a sealed 
vessel protected from light. After incubation, the fabric was briefly rinsed with pure water to 
remove residual guest molecules. Differential interference contrast (DIC) and fluorescent (488 nm 
& 561 nm) confocal images taken again to demonstrate guest molecule co-localization 
(CHATPER 4 Figure 4.4A Right). 
!! III.7.2 Sulforhodamine-Labeled P450 Loading into CJ-LPCs 
Rinsed fabric samples containing conjugated CJ-LPCs labeled with NHS-fluorescein were 
placed in 50 mM HEPES, 150 mM NaCl, 10% Glycerol pH 7.5 and imaged under brightfield 
light(DIC), 488 nm laser light (CJ-LPC fluorescein) and 561 nm laser light (to test for crystal 
intrinsic fluorescence), see CHAPTER 4 Figure 4.4B Left. After imaging, the buffer was removed 
and 500 µL of 50 mM HEPES, 150 mM NaCl, 10% Glycerol pH 7.5 containing cytochrome P450 
labeled with sulforhodamine 101 acid chloride (NHS-TexasRed) was added directly to fabric 
samples. Time-lapse imaging was immediately started using the same settings as before. Images 








Figure III.4. Time-lapse images of sulforhodamine-labeled P450 (red) loading into GA cross-linked CJ-LPCs (green) conjugated to 
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